CPC16 Precongress Newspaper by CloserStill Media

Sim Man 3G returns

Full programme and session descriptions

SEE PAGE 3

Congress floorplan and exhibitors list SEE PAGE 12

BNF

SEE PAGE 8

24/7

@CPCongress

The Clinical Pharmacy Congress Network

www.pharmacycongress.co.uk/facebook

Clinical. Production. Procurement. Optimisation. Whatever your role in pharmacy, we’ve got it covered! The clinical skills of pharmacy professionals are being discussed everywhere. Whatever role you have, bringing increased knowledge of medicines and the understanding of how to achieve better financial and clinical outcomes from those medicines if becoming more important. That is why The Clinical Pharmacy Congress this year expects over 2,300 pharmacy professionals to attend across the two days. It is not just the 76 hours of accredited education on offer that is important, Congress provides an unequalled opportunity for networking with the thought-leaders in the profession.

Clinical pharmacy – a future view Join us at ExCeL London, on April 22-23 and don’t miss the keynote address from Dr Bruce Warner, Deputy Chief Pharmacist at NHS England. See the winners of the ‘Clinical Pharmacy Congress Awards’ to gain inspiration from those leading the implementation of innovative new services. And, hear about both new and advanced roles within clinical pharmacy practice. Don’t miss sessions discussing the emerging new roles for clinical pharmacists in general practice, care homes, emergency care and embedded pharmacists in ward MDTs. Visit the Congress Education Hub where visitors can interact with representatives from leading universities – perhaps you can find the advanced course to give your expertise and career a boost?

More conference work streams Congress has maintained seven successful work streams from last year including Keynote, Leadership, Clinical, Medicines Optimisation, Innovation & Technology and the Strategy and Policy Forum. This conference programme is delivered by a world-class faculty of speakers, led by Dr Bruce Warner who is

PRE CONGRESS NEWSPAPER 2016

CSUs: Autonomy brings opportunity and risk Significant opportunities - but with new risks and much keener competition - will become the watchword for England’s Commissioning Support Units (CSU), as they progress along their individual journeys of autonomy, North East Commissioning Support Unit managing director Stephen Childs has said. And, spelling out these challenges, he says: “Commissioning customers and their stakeholders will have to strive to balance the enormous challenge of delivering high quality care within an increasingly pressured budget today - whilst designing a more efficient, integrated system that better serves the needs of patients tomorrow.” Since their establishment following the NHS reorganisation of 2012, England’s CSUs – organisations brought to life within the NHS to offer support services to NHS commissioners – have been expected to become autonomous bodies.

ably supported by a variety of specialists from the Department of Health, NHS England and the GPhC, amongst others. This year we have added the new Clinical Pharmaceutics and Technical Services stream, which has been programmed in conjunction with the Technical Specialist Education and Training Group (TSET) and the Radio Pharmacy Group with content for those working in quality assurance / quality control, radiopharmacy, aseptic services, production and manufacturing as well as procurement services and clinical trials. This year’s Congress delivers a unique range of educational sessions, from the medicines legislation and pharmacy regulation to advanced clinical knowledge and skills. Don’t miss some very topical issues such as antibiotic stewardship, medicines use in learning disabilities, dementia care, automation and technology. There are some intriguing titles: • • • •

Cancer medicines: Making the unaffordable affordable through medicines optimisation Health and justice pharmacy practice Steps to pharmacy heaven A career in mental health pharmacy

If you don’t know what these are about you might just have to go and participate! CONT. P3

And, by the end of this year – some three years after the original transition to autonomy deadline was first mooted - CSUs will be expected to apply to NHS England for validation or assurance that they are ready to grasp this nettle. Autonomy from the NHS will rapidly thrust CSUs into an environment where NHS commissioners, and other customers, are free to adopt – or abandon –the CSU’s support service offer. Therefore, having a quality service offer that lifts the capacity and capability of the commissioning system will be vital to the autonomous CSU’s ongoing financial success. “CSUs have no guarantee of winning income if they are not the first choice of customers,” NHS England has warned in a Board report from 2014.1

Benefits of autonomy As NHS England hosted organisations, CSUs are legally obliged to observe rules common to the public sector, such as those relating to procurement, formal financial control, management of risk, and nationally set staffing policies. But, in an increasingly competitive environment, this regime significantly constrains CSUs’ ability to respond to customers’ needs in an increasingly competitive environment. CONT. P6

Education partners:

UK Renal Pharmacy Group

www.pharmacycongress.co.uk

We’re in your corner

V ON S ISIT US TAND D30 pharm acyc April 2 ongress.c 2nd o.uk 23rd E xCeL L 2 ondon 016

SAFER PREPARATION

OPTIMAL VASCULAR ACCESS

SAFER ADMINISTRATION

BD provides solutions to protect you and your patients Backing you up with a complete portfolio of chemotherapy infusion products bd.com/uk ©2016 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.

www.pharmacycongress.co.uk

Continued from page 1

Bigger Poster Zone The Poster Zone has expanded and more than 100 posters will be displayed over the two days giving you access to grass roots learning and the opportunity to share best practice across the profession.

The Clinical Pharmacy Congress is organised by CloserStill Media Healthcare Limited George House, Coventry Business Park, Herald Avenue, Coventry CV5 6UB. Tel: 02476 717151

Simulation Training The Simulation Zone is back again. It was so popular last year that it booked up the first morning. “This new feature of the event has real value for pharmacy professionals and we’re really glad to be back. Delegates liked the fact that it bridged the gap between theory and real life, and offers a new, safe and exciting way of learning” said Nick Warren, Senior Lecturer, Non-Medical Prescribing Course Leader – School of Pharmacy and Biomedical Sciences, University of Portsmouth. Check the programme inside for the timetable and experience hands on simulation training in asthma, COPD and diabetes scenarios.

Networking “It’s a massive opportunity to come and engage with colleagues, meet new people and build relationships” said Dr Catherine Duggan, Director of Professional Development and Support, Royal Pharmaceutical Society. “Congress is a very good event and we are proud to be hosting the leadership theatre once again.” There are plenty of opportunities to catch up with colleagues, alumni friends and professional peers at the free networking drinks reception.

Exhibitors There will be at least 150 product and service suppliers, all of which can been see on page 12. Everything from new medicines, through education providers to robots. You will also find specialists that can translate the contents of your labels into the language of your local population and companies that might be able to find you that next important job in your career ladder, so make sure you allocate time to the show floor.

Quality Education The two-day conference programme is accredited by the Royal Pharmaceutical Society (RPS) and programmed in conjunction with Centre for Pharmacy Postgraduate Education (CPPE), the

www.pharmacycongress.co.uk RPS and UK Clinical Pharmacy Association (UKCPA) amongst others. Congress delegates will benefit from a wide range of education including lectures, seminars, debates and the hands on simulation exercises. Whether you are a chief pharmacist, pharmacy technician, working in production or advisor to clinical pharmacy, The Clinical Pharmacy Congress has something for you. Congress Director Laura Shapiro says: “It is clear that there is continuing pressure on everyone in the NHS to ‘work smarter’ with fewer resources. From debating the professional issues related to clinical leadership and quality improvement, to the development of innovative cross-disciplinary working by GPs and pharmacists, the Clinical Pharmacy Congress gives delegates the skills and the opportunities they need to develop excellence in patient care.”

Clinical Pharmacy Congress Awards Laura Shapiro, Congress Director is delighted to announce the launch of the Clinical Pharmacy Congress Awards as a successor to the Best of Clinical Pharmacy Awards. The awards continue to celebrate and acknowledge successful individuals and teams within the pharmacy profession at all levels of their careers, and in all sectors of clinical pharmacy. New award categories have been added. These include: • • • •

Excellence in clinical leadership Excellence in hospital pharmacy practice Excellence in general practice pharmacy Excellence in clinical community pharmacy practice

More details of the shortlisted entries can be found on page 5

Laura Shapiro, Congress Director 02476 719 681, l.shapiro@closerstillmedia.com Mihir Patel, Marketing Manager 0207 013 4976, m.patel@closerstillmedia.com George Ives, Marketing Executive 0207 348 5256, g.ives@closerstillmedia.com Rebecca Royal, Senior Operations Executive 0207 348 5277, r.royal@closerstillmedia.com Louise O’Connell, Senior Operations Manager l.oconnell@closerstillmedia.com Claudia Nyamesah, Speaker Liaison 0207 348 5276, c.nyamesah@closerstillmedia.com Kate Jackson, Head of Conferences kate.jackson@closerstillmedia.com Lucy Pitt, Strategy Director - Healthcare l.pitt@closerstillmedia.com Alexia Maycock, Marketing Director a.maycock@closerstillmedia.com

Congress information

Simulation Zone Live simulation returns to Congress with the popular Sim Man 3G, this year hosted by University of Portsmouth School of Pharmacy and Biomedical Sciences. The sessions on offer are detailed below:

Enhanced triage in primary care Part task trainer devices will be used to demonstrate additional non-invasive investigations pharmacists in primary care can use to enhance patient care, leading to better informed signposting to other healthcare professionals. Use of part task trainers such as blood pressure arms, ear diagnostic trainers and otoscopes will be demonstrated.

Overview of clinical assessment for a patient suffering from an exacerbation of COPD. This case study explores the expanding role of the pharmacist in responding to acutely ill patients developing signs and symptoms of respiratory disease, such as COPD. A patient with symptoms of COPD will be presented using a human patient simulator. A discussion of patient parameters, including breath sounds and nursing observations will illustrate how pharmacists can prioritise interventions and make therapeutic recommendations based on current guidelines.

Medicines management issues in diabetic patients This case study explores the medicines management issues surrounding patients suffering with diabetes mellitus. A diabetic patient will be presented, using a human patient simulator. A discussion of patient parameters and nursing observations will illustrate the complexities of polypharmacy and co-morbidities often seen in diabetic patients.

Opening Times Friday 22nd April 08:30 – 18:15 (Networking reception 18:15 – 19:45) Saturday 23rd April 08:45 – 16:00

Overview of clinical assessment for a patient suffering from an acute asthma attack Michael Leech MRPharmS BSc (Hons) PGCE FHEA, Senior Lecturer and Teaching and Learning Coordinator - School of Pharmacy and Biomedical Sciences, University of Portsmouth Nick Warren MRPharmS BSc (Hons) Dip Clin, Senior Lecturer, Non-medical Prescribing Course Leader - School of Pharmacy and Biomedical Sciences, University of Portsmouth Michael Collins RN BSc (Hons) PGCE FHEA, Senior Lecturer in Clinical Skills, University of Sunderland

Travel Congress is located in ExCeL London’s Hall N6 which is located 10 minutes from Canary Wharf, in the heart of London’s Royal Docks. There is easy access to the venue via road and rail.

Rail & Tube The Jubilee Line is recommended as the quickest route towards ExCeL from Central London. Alight at Canning Town to change onto the Docklands Light Railway (DLR) bound for Beckton, getting off at Custom House. DLR trains toward the venue normally depart from platform 3. London Underground tickets are valid on the DLR. ExCeL London is located in zone 3.

Road When driving to ExCeL London follow signs for Royal Docks, City Airport and ExCeL. There is easy access from the M25, M11, A406 and A13. For Sat Nav purposes, we recommend using postcode E16 1DR. ExCeL London offers on-site car parking for 3,700 cars.

For further information, please visit the London ExCeL travel page. www.pharmacycongress.co.uk/travel

www.pharmacycongress.co.uk

Industry-led Symposia FRIDAY 22ND APRIL 09:00 - 09:45 Keynote Theatre Breakfast symposium: PCSK9 inhibitors: now that we have them, who should get them?* The presentation will highlight the mechanisms of action of PCSK-9 inhibitors and why there is such interest in their development. The session will also cover the role that this new class of medicines will play when added to statins in reducing raised cholesterol levels and the position of PCSK9 inhibitors following NICE guidance. Sotiris Antoniou, FFRPS MRPharmS MSc DipMgt Ipresc, Consultant Pharmacist, Barts Health NHS Trust

13:00 - 13:45 Keynote Theatre Lunch symposium: Biosimilars: A case example The advent of biosimilar therapies has provided further cost effective options in the treatment of a number of severe and chronic diseases. The first biosimilar etanercept, Benepali®, has recently been launched in the UK for the treatment of rheumatoid arthritis and other inflammatory diseases. The aim of this symposium is to provide an overview of the data from the phase I and phase III clinical programme that supported the approval of Benepali® as a biosimilar molecule. The potential impact that biosimilars might have on the treatment of rheumatic disease and the considerations that health care professionals will need to take will also be discussed. Professor Peter C. Taylor MA, BM, BCh, PhD, FRCP, FRCPE, Norman Collisson Professor of Musculoskeletal Sciences, Oxford University

12:45 - 13:30 Clinical Theatre 1 Lunch Symposium: Which therapy for which patient in AF – perspectives from clinical pharmacy This presentation will explore key considerations underlying the choice of NOAC therapy based on a patient’s characteristics, and will review the clinical data supporting the use of NOACs for particular patient groups. Sharing of clinical experience and discussion of hot topics for clinical pharmacists, such as reversing the activity of NOACs, will be encouraged and welcomed throughout the presentation. Sotiris Antoniou, FFRPS MRPharmS, MSc, Dip Mgt, Ipresc, Consultant Pharmacist, Barts Health NHS Trust

17:30 - 18:15 Clinical Theatre 1 Unique patient populations: prioritisation of patients with hepatitis C Dr Dan Forton, Phd FRCP, Consultant Hepatologist and Reader in Hepatology, Associate Medical Director (Research), Department of Gastroenterology and Hepatology, St George’s Healthcare NHS Trust

12:45 - 13:30 Clinical Theatre 2

Lunch symposium: HER-2 positive breast cancer: Changing the neoadjuvant landscape Dr Verrill will review the aims of neoadjuvant therapy for HER2+ breast cancer patients and the data behind the latest licenced options for clinical use and what this means for patients and clinicians. Mark Verrill, Consultant Oncologist, Newcastle

14:15 - 15:00 Clinical Theatre 2 Partnership working to improve the management of psoriasis Jim and Andrew will outline how their organisations collaborated to improve the management of psoriasis at Royton and Crompton Family Practice and beyond. Including future opportunities for continued collaboration. Jim McArdle, Director Interface Clinical Services, ICS and Andrew Vance, GP, NHS Oldham CCG

13:00 - 13:45 Leadership Theatre

Lunch symposium: Pharmacy - Critical to identifying, managing and reducing the emerging trend of addiction to opioid analgesics An overview of the current workshops being delivered across Scotland, including background, prevalence, an exploration of how to effectively engage with people who may have Opioid Analgesic Dependence and how to support better management and reduction of OAD Annamarie McGregor MRPharmS, Practice Development Lead, Royal Pharmaceutical Society and Duncan Hill MRPharmS, Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

09:00 - 09:45 Medicines Optimisation Workshops

Breakfast symposium: Implementing Biosimilars: practical considerations for pharmacists Biosimilars are generating enormous interest due to the potential costs savings. Appropriate use of these molecules is complex and requires careful consideration by a multidisciplinary team. The symposium will tackle the key issues surrounding the implementation of biosimilars, discuss best practice, and provide practical advice for pharmacists. Hosted by Sue Saville (Television Health Correspondent) the symposium will allow the audience to have an interactive discussion with an experienced faculty, comprising Laura Bromilow (Bolton NHS Foundation Trust), Zoe Cole (Salisbury District Hospital) and Caron Underhill (Southampton University Hospital NHS Trust). Sue Saville, Broadcaster/Medical Journalist, ITN London, Zoe Cole, Consultant Rheumatologist, Salisbury District Hospital , Caron Underhill, Specialist Biologics Pharmacist, Southampton University Hospital NHS Trust and Laura Bromilow, Rheumatology Pharmacist, Royal Bolton Hospitals NHS Trust

12:45 - 13:30 Strategy and Policy Forum Lunch symposium: Driving a better homecare experience for patients through small, continuous improvements A session to explore how incremental improvements to operations can have a significant impact on productivity, patient safety and experience Susan Gibert, Homecare Medicines Pharmacist , Thames Valley and Wessex Pharmacy Procurement Service, Stephen Cook, Director of Pharmacy and Quality, Bupa Home Healthcare and Alan Davey, Director of Operations , Bupa Home Healthcare = Hot drink and pastry will be provided = Lunch bag will be provided

12:45 - 13:30 Innovation & Technology Forum Lunch symposium: Automating medication dispensing to drive efficiencies Find out how something as simple as replacing traditional drugs cabinets with automated dispensing cabinets and systems really does offer hospitals a great opportunity to improve the way they work, save money and staff time and improve patient safety – helping Trusts to achieve many of the recommendations outlined in Lord Carter’s recent report. Learn about one hospital’s automated medicines management journey and the way it’s making a difference to patients and staff. David Buller, UK&I Sales Director for Omnicell Philip Dean, Head of Pharmacy & Quality Control Laboratory Services North Tees and Hartlepool NHS Foundation Trust and Philip Dean, MPharm MRPharmS GPhC, Head of Pharmacy & Quality Control Laboratory Services, North Tees and Hartlepool NHS Foundation Trust

14:00 - 14:30 Innovation & Technology Forum Connecting patients to medication through technology Darren Taylor and Justin Moore from CitySprint Healthcare, have teamed their wealth of delivery experience with their Healthcare Industry expertise, to look at how delivery has changed so many industries over the past few years and why Healthcare needs to catch up. The presentation will focus on the importance of track and trace technology within hospitals and for delivery medications to homes, as well as identifying key areas within the pharmaceutical industry that could be enhanced through delivery. Justin Moore, Sales and Marketing Director, CitySprint and Darren Taylor, Logistics Director, CitySprint

12:45 - 13:30 Clinical Pharmaceutics and Technical Services Forum Lunch symposium: Quality standards in specials

SATURDAY 23RD APRIL 09:00 - 09:45 Keynote Theatre Breakfast symposium: Quantifying a case for change: How IMPACT 2 justifies improved glycaemic control as health care priority The seminar will be a presentation and discussion about IMPACT Diabetes 2 research which shows that improvement in blood glucose levels can provide significantly improved outcomes for the 3.3 million people diagnosed with diabetes in the UK. Mike Baxter Ph.D., FRCP, Consultant Advisor (Diabetes), Sanofi

The Congress is delighted to present this wide variety of sponsor delivered content across all the theatres throughout the two days. Many sessions will offer you the opportunity to get free food either breakfast – (hot drink and pastry) or lunch bags. Spaces at sessions can be preselected through the online portal, found in your confirmation email.

www.pharmacycongress.co.uk

12:45 - 13:30 Keynote Theatre

Lunch symposium: Pharmacists as leaders: achieving consensus in the localimplementation of NICE TAs. A Heart failure case study Pharmacists are key members of the local leadership team,responsible for achieving local consensus on the implementation ofNICE Technology Appraisals. Positive NICE TAG requires implementation at a local level but affordability discussions in localhealth economies are key. As a case study, this symposium will look at the adoption of a new medicine for heart failure. Join us for an interactive session that will help enable you to achieve local consensus quickly and help to reduce geographical variation inpatient pathways. This will be an interactive session to help enable delegates to achieve consensus on local treatment guidelines quickly and help to reduce geographical variation in patient pathways.

12:45 - 13:30 Clinical Theatre 1 Lunch symposium: Medicines Management: Enhancing patient and staff safety In the NHS medication must be stored, dispensed and disposed safely by law and this is regulated by the CQC. Drug enclosures must never be left open and unattended, and must be in constant supervision by staff, but this is very difficult to achieve in practice. This presentation discusses medication safety, why mistakes happen and describes simple credible solutions to prevent errors in medicines management, safeguarding both patients and staff. Peter Young, MbChB, FRCA, FICCM, MD, Consultant Critical Care, The Queen Elizabeth Hospital, Kings Lynn, Maryanne Mariyaselvam, BSc MBBS, Clinical Research Fellow Cambridge University Hospitals, Patsy Tipene, RN, Dip PSN, Critical Care Senior Nurse, The Queen Elizabeth Hospital, Kings Lynn, Darcy Pearson, MBChB, MRCP, FRCA, FFICM, Consultant Critical Care, The Queen Elizabeth Hospital, Kings Lynn, John Gibson, MbChB, MA, FRCS, FRCA, FICCM, Consultant Critical Care, The Queen Elizabeth Hospital, Kings Lynn and Parvez Moondi, MBcChB, BSc, FRCA, EDICM, FFICM, Consultant Critical Care , The Norfolk and Norwich Hospital

12:45 - 13:30 Leadership Theatre Lunch Symposium: Value and outcomes in Type 2 diabetes Dr Marc Evans, Consultant Endocrinologist, Cardiff

09:00 - 09:45 Innovation & Technology Forum

6 CPPE and the organisers of The Clinical Pharmacy Congress are delighted to provide you with an overview of the shortlisted candidates for the 3rd Clinical Pharmacy Congress Awards. These four awards which look to celebrate excellence in your profession will be presented by Dr Bruce Warner and Professor Christopher Cutts preceding Dr Warner’s Keynote address (Clinical Pharmacy – a future view) at 11:30am on Friday 22nd April in the main Keynote Theatre. Excellence in community pharmacy clinical practice The judging panel are looking for an outstanding person, team or project that has made a significant contribution to clinical pharmacy in community pharmacy in the UK. This could be a career long contribution or a single initiative that has had a major impact in recent times. Shortlisted entries are: Community pharmacy chronic pain pilot West Dunbartonshire Superdrug Healthcare - Ascot rehab (Pharmacy Support) Superdrug - Innovation in substance misuse Weldricks Pharmacy, Scunthorpe Excellence in clinical leadership The judging panel are looking for an outstanding person who has made a significant contribution to pharmacy leadership in the UK. This could be a career long contribution or a single initiative that has had a major impact in recent times. Shortlisted entries are: An investigation into the effectiveness of the WHSCT warfarin / enoxaparin bridging protocol Antimicrobial pharmacist input to diabetic foot outpatient clinic Electronic pharmacist-physician communications in a highly computerised hospital: timeliness of action in practice.

Evaluating the impact of a Pharmacy Homecare Team (PHT) at Kettering General Hospital (KGH) over a three month period. Hardeep Syan, Medicines Management Technician, Birmingham Women’s Hospital NHS Foundation Trust Implementation of electronic prescribing, administration and patient record system for chemotherapy across hospital sites Investigating Medication Prescribing Accuracy for Critical Error Types (iMPACT) Excellence in pharmacy in general practice The judging panel are looking for an outstanding person, team or project that has made a significant contribution to clinical pharmacy in general practice pharmacy in the UK. This could be a career long contribution or a single initiative that has had a major impact in recent times. Shortlisted entries are: Antimicrobial Stewardship in Primary Care, Kettering General Hospital, CNWL, MKCCG, Southampton NHS Trust Atif Shamim Programme Director, CEPN Pharmacy Project HEE KSS, 3rd Floor, Crawley Hospital, West Sussex Benjamin Kelly-Fatemi Lead Pharmacist – Newcastle Care Homes Programme Dudley CCG Practice Based Pharmacist Team Germaine Swarbrick, GP Practice Pharmacist, Severn Valley Medical Practice, Can a GP Practice Pharmacist take on the prescription administrative caseload of a GP?

The impact of pharmacist led medicines reconciliation in critical care

Medicines quality team Sandwell & West Birmingham Clinical Commissioning Group NHS North of England Commissioning Support Pharmacist-led review of psychotropic medicines for challenging behaviour in the learning disability (LD) population of Trafford, Greater Manchester West (GMW) Mental Health NHS Foundation Trust Pharmicus (Gateshead CBC Ltd) Polypharmacy medication reviews for patients living in their own homes, Guildford & Waverley CCG

12:45 - 13:30 Clinical Pharmaceutics and Technical Services Forum

the clinical setting. Orlando Jaquez MA, BM, BCh, PhD, FRCP, FRCPE, Senior Program Manager, Medical Affairs, Biosimilars, Biogen

An evaluation of improving pharmacy services to acute medicine to support patient flow.

Impact of Pharmacist-led Acute Kidney Injury (AKI) Alert Reports on its Recognition and Management

Breakfast symposium: Increasing nursing efficiency and medicine management security using intelligent locking This presentation explains how Abloy’s unique PROTEC2 CLIQ electro-mechanical lock system can be incorporated into new or existing drug cabinets to release valuable nursing time back into patient care. Shaun Powell, General Sales Manager, ABLOY UK

Lunch symposium: Manufacturing matters: The science behind biosimilars of advanced Biologics This presentation will discuss the manufacture of biosimilar versions of advanced biologics. It will illustrate the critical importance that the quality and robustness of the manufacturing process plays in the development of these molecules. Further, it will show that identification of critical quality attributes at the molecular level is the essence of developing a molecule that is highly similar to the originator in

The judging panel are looking for an outstanding person, team or project that has made a significant contribution to clinical pharmacy in hospital pharmacy in the UK. This could be a career long contribution or a single initiative that has had a major impact in recent times. Shortlisted entries are:

Rachel Mackay, Head of Medicines Management, Guildford & Waverley CCG

Excellence in Hospital Pharmacy Practice

For the full abstracts please visit www.pharmacycongress.co.uk/awards

www.pharmacycongress.co.uk

CSUs: Autonomy brings opportunity and risk

RPS accreditation

Continued from page 1

CloserStill Media and the Royal Pharmaceutical Society (RPS) are delighted to confirm that, for the third consecutive year, the Clinical Pharmacy Congress (CPC) 2016 has been accredited by the RPS. Accreditation with the RPS means that the event complies with the RPS Accreditation Standards and Criteria for quality and content and that participation, together with effective evaluation, will enable visitors to gain skills, knowledge and attributes for their professional development.

Autonomy, appropriately framed, can give CSUs a number of key freedomsi, notably: • • • •

Determine their own business strategy, and pursue individual routes to success Take managed risks Secure flexible investment funding Enter into alliances and sub-contracts simply and quickly.

What form will the autonomous CSU take? Several legal structures have been suggested as potential models for the new, autonomous CSUs, and each will demand a robust commercial response in areas such as effective contracting and contract management, workforce management, and asset and intellectual property management2: •

Social enterprise, which will have a public, binding and overriding social purpose (taking the legal form of a community interest company limited by guarantee)

•

Staff mutual, which will abide by the seven principles of the cooperative movement, including one member one vote and concern for the community (taking the legal form of an industrial and provident society)

•

Customer controlled social enterprise, which would be akin to the in-house department of the customers, which effectively exempts customers from going through formal procurement to secure its services (taking the legal form of a community interest company limited by guarantee) Joint venture, taking the legal form of a company limited by shares. Safeguards will be necessary to deliver value to the taxpayer.

Working smarter: Find out how CCGs operating in this changing world of commissioning support services will be keen to hear how England’s CSUs plan to help them meet their local efficiency challenges. The NHS workforce has already begun to kick back over work place pressure and CCGs will be looking for solutions that help the workforce to work smarter rather than harder. With this in mind, there has never been a better time for the

NHS in England to pull together, build bridges and keep abreast of the ever changing nature of clinical practice. Taking place at ExCel, London, on April 22-23, 2016, The Clinical Pharmacy Congress has become the go-to conference and exhibition of the year for commissioning leads, as well as grass-roots practitioners in clinical pharmacy. New among the education streams for the 2016 event is the Clinical Pharmaceutics & Technical Services Theatre with content for those working in quality assurance/quality control, radio-pharmacy, aseptic services, production and manufacturing as well as procurement services and clinical trials. In total, the Congress conference offers eight education streams offering a total of 79 hours’ of thought-leadership, practical pointers and networking opportunities in key clinical subjects as well as technology, medicines optimisation, procurement, leadership and strategy and policy. Where else will you find all under one roof 100 world-class speakers, as well as the expertise and innovation offered by over 150 suppliers exhibiting new medicines, specialist pharmacy technology, post-graduate training, recruitment and equipment? References 1 BOARD PAPER - NHS ENGLAND. https://www.england.nhs.uk/wpcontent/uploads/2014/02/item4-board-0114.pdf 2 Capsticks report. Facing the future challenges for NHS commissioning support. http://www.capsticks.com/assets/Uploads/COMS3.pdf

WIN A WEEKEND IN PARIS! for two people - including return travel via Eurostar. Collect a postcard in the registration area upon entering The Clinical Pharmacy Congress to be in with a chance of winning this fantastic prize! Visit the named exhibitors at The Congress and answer a short question about their products and services, getting your postcard stamped as verification. Once completed, all correctly answered cards will be entered into a prize draw to win a Weekend Break for two in Paris!

(terms and conditions apply).

RPS accreditation involves a rigorous process of quality assurance against agreed RPS accreditation standards. By successfully achieving RPS accreditation the organisers of CPC have demonstrated the event meets recognised RPS standards for quality and content. RPS accreditation ensures that you can be assured that the sessions and presentations at this conference will: • •

•

Contribute to your Continuing Professional Development (CPD) Support you with your wider professional development, including professional development as part of your RPS Faculty portfolio Contribute to supporting you with delivering excellent pharmacy practice and patient care

Clinical Pharmacy Congress Director Laura Shapiro said: “We are delighted to receive accreditation by the RPS. The RPS has positioned itself as the place for pharmacists to go to advance their professional practice. These aims resonate exactly with the objectives of the Clinical Pharmacy Congress, and we look forward to helping pharmacists exceed their aspirations and ambitions for clinical practice development again at the 2016 show.”

Post Graduate Pharmacy Training The Education Hub will return for 2016 – There will be a specific area (near the entrance) on the exhibition floor where you can learn about a variety of different post-graduate training courses from seven leading Universities and Colleges including:

www.pharmacycongress.co.uk

Celebrating inspirational people and places! Christopher Reeve described a hero as “an ordinary individual who finds the strength to persevere and endure in spite of overwhelming obstacles”. Bob Dylan said “I think of a hero as someone who understands the degree of responsibility that comes with freedom.” At the Clinical Pharmacy Congress this year Pharmacist Support – the profession’s independent charity – will be hosting an inspiration gallery, a place to reflect on the things and the people that bring you joy. Their stand this year will not only celebrate the charity’s 175th anniversary year, it will celebrate the heroes, icons and places that help create a positive psychology that is so important for our wellbeing. In the gallery they’ll be sharing images, quotes and scenes as well as tips on how to better harness your own happiness and be encouraging visitors to share their personal inspirations. For Eddie Izzard it’s Nelson Mandela. For Chief Pharmaceutical Officer for Scotland Professor Rose Marie Parr it’s Professor Bill Bowman who established the Department of Pharmacology at the University of Strathclyde. Marie described him as “an inspirational teacher, a brilliant lecturer, a walking encyclopaedia of pharmacology and a mentor to numerous pharmacists and pharmacologists around the globe.” We all have our own things - quotes, people and places - that give us that much needed boost when times get tough. Visit the inspiration gallery to find out more at stand C50. Everyday Pharmacist Support helps people facing a range of life changing events. They understand the difficulty and uncertainty that results from situations such as a loved one falling ill or a sudden loss of work. Simple, effective interventions can make the difference between sinking or swimming.

Last year alone the charity provided over 2800 individual acts of support to pharmacists and their families, former pharmacists, trainees and Mpharm students struggling with a range of issues. Their free and confidential services include an information and enquiry service, wellbeing services (that include workshops, a listening ear helpline, telephone counselling, e-therapy and online support tools), financial assistance in times of hardship, specialist advice in the areas of debt, benefits and employment law and addiction support.

Christopher Reeve as Superman

2016 marks a significant milestone for the charity that, 175 years on, continues to respond to the needs of pharmacists today and to provide relevant and effective support to those in the profession. As a charity Pharmacist Support relies on

the generosity of pharmacists and pharmacy organisations to be able to continue its work and the Clinical Pharmacy Congress is delighted to be supporting this worthy cause. You can donate today via the Clinical Pharmacy website or at pharmacistsupport.org.

www.pharmacycongress.co.uk

KEYNOTE THEATRE

Sponsored by:

Peter C Taylor Grainne d’Ancona

Bruce Warner

FRIDAY 22ND APRIL

09:00 09:45

SATURDAY 23RD APRIL

Breakfast Symposium : PCSK9 Inhibitors: Now that we have them, who should get them? ** The presentation will highlight the mechanisms of action of PCSK-9 inhibitors and why there is such interest in their development. The session will also cover the role that this new class of medicines will play when added to statins in reducing raised cholesterol levels and the position of PCSK9 inhibitors following NICE guidance. Sotiris Antoniou FFRPS MRPharmS MSc Dip Mgt Ipresc, Consultant Pharmacist, Barts Health NHS Trust

09:00 09:45

Delivered by

10:15 11:00

What’s new in cardiology This presentation will highlight a number of new drugs to be introduced into clinical practice during 2016 including: • salcubitril / valsartan in the management of chronic heart failure • PCSK9s in the treatment of familial and non familial hypercholesterolaemia • edoxaban for the treatment and secondary prevention of VTE and for the prevention of AF-related stroke Relevant NICE guidance and quality standards will also be discussed, such as the revised NICE guidance for ezetimibe Helen Williams MRPharmS FFRPS PGDip Cardiol Ipresc, Consultant Pharmacist for Cardiovascular Disease, Southwark CCG

13:00 13:45

The Best of the Clinical Pharmacy Awards 2016 followed by the Chief Pharmaceutical Officers’ keynote address: “Clinical Pharmacy – a Future View” Building on the Carter Report and recent Community Pharmacy announcements, this presentation will provide a view of where clinical pharmacy goes from here and how it can prepare itself for the future. Bruce Warner BSc MSc DPharm MRPharmS, Deputy Chief Pharmaceutical Officer, NHS England Lunch symposium: Biosimilars: A case example ** The advent of biosimilar therapies has provided further cost effective options in the treatment of a number of severe and chronic diseases. The first biosimilar etanercept, Benepali®, has recently been launched in the UK for the treatment of rheumatoid arthritis and other inflammatory diseases. The aim of this symposium is to provide an overview of the data from the phase I and phase III clinical programme that supported the approval of Benepali® as a biosimilar molecule. The potential impact that biosimilars might have on the treatment of rheumatic disease and the considerations that health care professionals will need to take will also be discussed. Peter C. Taylor MA BM BCh PhD FRCP FRCPE, Norman Collisson Professor of Musculoskeletal Sciences, Oxford University

10:15 11:00

14:15 15:00

Specialist commissioning update This session will provide delegates with an update and overview of the current commissioning of high cost medicines that are the commissioning responsibility of NHS England Specialised Services. The session will include: 1. an overview of how medicines are commissioned and the governance process which is used to prioritise medicines. 2. a description of how area hubs are working with Trusts to identify high cost medicine budgets 3. an update on the Medicines Optimisation CRG 4. an update on the CDF and hepatitis C strategy Malcolm Qualie MSc BSc MRPS MRPC, Pharmacy Lead, Specialised Services, NHS England In association with

11:30 12:15

NHS Specialist pharmacy services - what is it and getting it right for the future? Justine Scanlan, Head of Specialist Pharmacy Service, NHS England In association with

12:45 13:30

Delivered by Care Quality Commission: National update This presentation will update attendees of the work of the Medicines Optimisation Team within CQC. This includes: • Our medicines optimisation strategy • Regulating the safe and effective use of medicines in all care settings Learning Outcomes: 1.You will better understand the role of the regulator in medicine optimisation 2. You will know the themes that have emerged from our inspections to date 3. Your will understand our plans to improve how we regulate medicines optimisation. Sarah Billington FRPharmS, Head of Medicines Optimisation, Care Quality Commission

Breakfast symposium: Quantifying a case for change: How IMPACT 2 justifies improved ** glycaemic control as health care priority The seminar will be a presentation and discussion about IMPACT Diabetes 2 research which shows that improvement in blood glucose levels can provide significantly improved outcomes for the 3.3 million people diagnosed with diabetes in the UK. Dr Mike Baxter PhD FRCP, Consultant Advisor (Diabetes), Sanofi and Richard Hudson PhD, Health Outcomes Manager, Sanofi Delivered by

In association with

11:30 12:30

Sarah Billington

Malcolm Qualie

Lunch symposium: Pharmacists as leaders: achieving consensus in the local implementation of NICE TAs. ** A Heart failure case study Pharmacists are key members of the local leadership team, responsible for achieving local consensus on the implementation of NICE Technology Appraisals. Positive NICE TAG requires implementation at a local level but affordability discussions in localhealth economies are key. As a case study, this symposium will look at the adoption of a new medicine for heart failure. Join us for an interactive session that will help enable you to achieve local consensus quickly and help to reduce geographical variation inpatient pathways. This will be an interactive session to help enable delegates to achieve consensus on local treatment guidelines quickly and help to reduce geographical variation in patient pathways. Delivered by

14:00 14:45

* Inpatient diabetes for pharmacists This session will discuss the issues around diabetes in secondary care in a number of care settings. It will begin to equip pharmacists with the basic up to date knowledge around diabetes and why it is important. Philip Newland-Jones MPharm MRPharmS MSc IPP, Advanced Specialist Pharmacist Practitioner, University Hospital Southampton NHS Foundation Trust

In association with

15:30 16:15

In association with

Shared decision making for Type 2 Diabetes Involving the patient in decisions about them as an equal partner is an essential part of managing their condition. Good management at home and in the community should result in fewer emergency contacts with health professionals and admissions to hospital. In this session we will discuss the essential components of Shared Decision Making (SDM) in relation to Type 2 diabetes, and demonstrate some ways of supporting patients in coming to their decision. This practical session will work through the principles of shared decision making with the patient, and how to implement the principles outlined in the NICE guidance on Type 2 diabetes. Using case studies, participants will use tools (such as patient decision aids, self-management plans) which can support patients in becoming partners in decisions about their care. Gill Eddy BPharm MSc MRPS, NICE Medicines Prescribing Programme (MPP) Regional Technical Adviser (East, Midlands and Wales), NICE and Zoe Girdis BPharm MPRPS PIP Diploma Clinical Pharmacy, NICE Medicines Prescribing Programme (MPP) Regional Technical Adviser (South of England and Channel Islands) and Pharmacist Independent Prescriber, NICE

15:00 15:45

* Pharmacy led paediatric Asthma reviews Learn how paediatric asthma treatment differs to the adult world and how pharmacists have a key role to play in improving patient outcomes Andrew Lilley MPharm MRPharmS DipClinPharm, Specialist Paediatric Pharmacist Respiratory, Alder Hey Children’s Hospital In association with

In association with 16:30 17:15

17:30 18:15

Breaking news COPD: From the cradle to the grave This session will discuss the factors contributing to developing COPD and the high value interventions necessary to manage the disease. Grainne d’Ancona, Principal Pharmacist, Respiratory, Sleep Medicine and Clinical Lecturer, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London In association with

Sponsored by:

Phil Freeman Lucy Hedley

Julie Shenton

FRIDAY 22ND APRIL

09:00 09:45

SATURDAY 23RD APRIL

Medication safety pearls * The aim of this session is for practitioners to present current issues in medication safety from their organisations and inspire colleagues to find out how similar risks are managed in their own organisations Kevin Gibbs MRPharmS, Clinical Pharmacy Manager, University Hospitals Bristol NHS Foundation Trust; Nicola Wake, Lead Clinical Pharmacist – Safety and Governance, Northumberland Healthcare NHS Foundation Trust and Gillian Cavell, Consultant Pharmacist - Medication Safety King’s College Hospital NHS Foundation Trust

09:00 09:45

How is the pharmacy profession supporting clinical research? Presenting an overview of why the pharmacy profession, along with their patients, should actively engage in clinical research. It will provide an outline of the pharmacy clinical research infrastructure, roles that pharmacy plays, and some of the new initiatives in this area of practice. Mandy Wan MPharm MSc MRPharmS, Lead Paediatric Clinical Trials Pharmacist, Evelina London Children’s Hospital / NIHR Clinical Research Network: Children and Julie Shenton MPharm MRPharmS, Lead Pharmacist, NIHR Clinical Research Network: West Midlands

10:15 11:00

Understanding medication administration errors in hospitals and what pharmacy teams can do to help This interactive presentation draws on research evidence to introduce medication administration errors in hospitals to delegates. First, the frequency of these errors and which drugs are involved will be described, including the potential impact on patients. Following this the underlying causes of these errors will be discussed, drawing on the accounts of responsible parties. Finally, different interventions to reduce administration errors will be reviewed, with emphasis on where pharmacy teams could contribute to improvement efforts. Richard Neil Keers MPharm PGDip PhD MRPharmS, Clinical Lecturer in Pharmacy, The University of Manchester

In association with

10:15 11:00

Tamara Khafadji

Mandy Wan

Enhancing the role of pharmacy professionals in the management of dementia (supporting primary care) This presentation will explore the vital role community pharmacies can play to support people affected by dementia. It will outline some of the unique challenges they face in accessing the services provided by pharmacies and will outline cost effective, easy to implement interventions which can make a significant difference. Phil Freeman, Executive Lead, Dementia Action Alliance In association with

12:45 13:30

Lunch symposium: HER-2 positive breast cancer: Changing the neoadjuvant landscape ** Dr Verrill will review the aims of neoadjuvant therapy for HER2+ breast cancer patients and the data behind the latest licenced options for clinical use and what this means for patients and clinicians Mark Verrill, Consultant Oncologist, Newcastle

11:30 12:15

Delivered by

Medicines management for Parkinson’s The presentation will cover a brief overview of Parkinson’s disease as a condition and then discuss the work of the Dudley Group Foundation Trust to improve the safety of medication taking by Parkinson’s patients whilst in hospital by audit and then re-audit. There will also be discussion about how the Trust has managed to improve in this area by an extensive educational programme. Janine Barnes FFRPS MRPharmS Pres PhwSI (Neurology), Neurology Specialist Pharmacist, Dudley Group Foundation Trust In association with

14:15 15:00

Partnership working to improve the management of psoriasis ** Jim and Andrew will outline how their organisations collaborated to improve the management of psoriasis at Royton and Crompton Family Practice and beyond. Including future opportunities for continued collaboration. Jim McArdle, Director Interface Clinical Services, ICS and Andrew Vance, GP, NHS Oldham CCG Delivered by

15:30 16:15

16:30 17:15

17:30 18:15

13:00 13:45

The challenge of polypharmacy to general practice This overview of polypharmacy from the perspective of UK general practice will review how we define the problem, its epidemiology, the challenges it presents to clinicians and patients, and the approaches that can potentially be implemented to address it. Rupert Payne PhD MRCGP FRCPE, Consultant Senior Lecturer in Primary Health Care, University of Bristol

Cystic Fibrosis : current challenges and opportunities A look at the current issues for patients with Cystic fibrosis in a time of emerging and difficult to treat transmissible pathogens, balancing extensive treatment burdens, set against the opportunities presented by personalised medicine and the new CFTR potentiators. Will cover disease state, treatment options, practical issues for pharmacists looking after these patients and look at the new agents recently licensed and on the horizon. Main focus on adult care. Clare Cox BPharm Dip Clin Pharm, CF Specialist Pharmacist, Papworth Hospital NHS Foundation Trust * Drug interactions with anti-cancer medication With the increasing number, diversity and long-term use of anti-cancer medications, drug interactions in Systemic Anti-Cancer Therapy (SACT) are becoming increasingly important. This presentation reviews common SACT drug interactions and an approach to manage them, with case studies. Literature examining the incidence and impact of interactions are presented and the importance of e-prescribing systems in identifying and managing interactions is considered. Nationwide data exploring Trusts’ approach to managing SACT interactions is also presented. Simon Matthews, Lead Gastrointestinal Cancer Pharmacist, The Royal Marsden NHS Foundation Trust

Lunch Symposium: Mission Remission: ‘What can pharmacists learn from sport? Marginal gains theory and medicines optimisation in Rheumatology.’ ** The symposium will focus on applying Marginal Gains theory, made famous in a sporting context, to Medicines Optimisation and will include a case study on how this can be applied specifically within Rheumatology. Sports psychologist Steve Bull will explore the topic of Marginal Gains, and Specialist Pharmacist Sarah Kerr will talk about how this can be applied within the Pharmacy setting. Dr Steve Bull, former Team Psychologist for Olympic Team GB and Sarah Kerr MRPharm MSc, Specialist Pharmacist for Commissioning, West Hampshire CCG Delivered by

14:00 14:45

Uveitis Uveitis is defined as inflammation of the uveal tract—the iris, ciliary body, and choroid. Most cases are idiopathic and presumed autoimmune; identifiable causes include trauma, infection, and systemic diseases, many of which are autoimmune. Treatment depends on cause but typically includes topical, locally injected, or systemic corticosteroids with a topical cycloplegicmydriatic drug. Anti-TNF drugs may be used in severe and refractory cases and recently they are some controversies in regard to commissioning these drugs by NHS England. Tamara Khafadji MRPharmS BSc (Pharmacy) PgDipPS PgDipClinPharm PgCertIP, Directorate Lead Pharmacist – Ophthalmology, City Hospital Sunderland NHS Foundation Trust In association with

15:00 15:45

* From Anticoagulants to Zinc, the never ending list of HIV drug interactions An insight into the many and varied interactions that occur between ARVs and commonly prescribed and OTC medicines and herbals. Lucy Hedley MPharm MRPharmS MFRPSI PGDipGPP IPresc, Senior Clinical Pharmacist - HIV & Infectious Diseases, University College London Hospitals NHS Foundation Trust In association with

In association with

www.pharmacycongress.co.uk

MEDICINES OPTIMISATION WORKSHOPS

Nina Barnett Helen Williams

Lesley Grimes

Liz Brown

FRIDAY 22ND APRIL

09:00 09:45

Breakfast Symposium: Implementing Biosimilars: practical considerations for pharmacists ** Biosimilars are generating enormous interest due to the potential costs savings. Appropriate use of these molecules is complex and requires careful consideration by a multidisciplinary team. The symposium will tackle the key issues surrounding the implementation of biosimilars, discuss best practice, and provide practical advice for pharmacists. Hosted by Sue Saville (Television Health Correspondent) the symposium will allow the audience to have an interactive discussion with an experienced faculty, comprising Laura Bromilow (Bolton NHS Foundation Trust), Zoe Cole (Salisbury District Hospital) and Caron Underhill (Southampton University Hospital NHS Trust). Sue Saville, Broadcaster/Medical Journalist, ITN London; Zoe Cole, Consultant Rheumatologist, Salisbury District Hospital; Caron Underhill, Specialist Biologics Pharmacist, Southampton University Hospital NHS Trust and Laura Bromilow, Rheumatology Pharmacist, Royal Bolton Hospitals NHS Trust

17:30 18:15

10:15 11:00

SATURDAY 23RD APRIL

9:00 9:45

Optimising care of patients on Anticoagulation A personal insight in to caring for patients requiring anticoagulation, the challenges with applying guidelines, evidence and tailoring discussions so that the patient understands and can implement an action. How to better ensure seamless care – what can pharmacy practitioners do to help? Sharron Gordon, IP FFRPS MRPharmS, Consultant Pharmacist Anticoagulation, Hampshire Hospitals NHS FT

10:15 11:00

From counselling to consultation: changing culture Patient counselling is an interesting term, something which is synonymous with pharmacy practice. There is a risk that counselling practice may encourage a unilateral handover of information, something which may make patients feel patronised and unaccepting of advice. This session addresses some of the more advanced skills which support the therapeutic relationship and promote a shift away from counselling toward true patient-centred consultation practice. Lesley Grimes, MRPharmS FHEA, Lead pharmacist, Learning development Centre for Pharmacy Postgraduate Education, University of Manchester

In association with

12:45 13:30

Lunch symposium: Patient pathway modelling in type 2 diabetes – the clinical and economic impact ** Diabetes is fast becoming a health epidemic for the NHS. People with diabetes are at a significantly increased risk of developing vascular complications and as a result an estimated 22,000 people with type 2 diabetes are dying each year from diabetes-related causes that could potentially be avoided. In addition to the impact on the patient, these complications cost the NHS an estimated £3.9bn each year, which accounts for over two-thirds of the total NHS spend in Diabetes. With around 200,000 people newly diagnosed with diabetes each year, it is critical that the increasingly stretched monetary and time resources within the NHS are best utilised in order to achieve improved outcomes for patients and cost-avoidance for the NHS. In this session we will explore the patient pathway in diabetes, and explore how varying costs can accumulate over time as a function of the differing pathways that patients experience in the NHS. Learning outcomes: 1. The aim of this session is to equip healthcare professionals with an understanding of the clinical and economic value of managing diabetes from both patient and provider perspectives. 2. Delegates will gain an improved understanding of; 3. Health Economic approaches to measuring quality of life 4. Effect of diabetes on society – its impact on life and work 5. Methodological aspects of diabetes modelling 6. Modelling diabetes disease progression and its complications 7. Quantifying the cost of diabetes and its complications 8. Application of health economics from population to patient Phil McEwan, Professor & Technical Director, Centre for Health Economics, Swansea University

11:30 12:15

14:15 15:00

In association with

15:30 16:15

Lets talk about pain This session aims to discuss the main issues affecting our interactions with people who have pain. Highlighting some of the language to avoid and also what to promote in order to support and encourage people to take a proactive, self-management approach to their pain. It aims to move away from simply talking about medication, using the psychosocial pain model as the basis of the contact. Emma Davies BSc MPharm DipClinPharm FFRPS MRPharmS, Advanced Pharmacy Practitioner in Pain Management, Abertawe Bro Morgannwg University Health Board

16:30 17:15

Emergency department pharmacists: Update on regional initiatives Presenting findings from national and West Midlands based pharmacy pilot work, guided by the study questions: “To what extent can pharmacists manage patients in the ED?” “What extra training is needed to create an advanced clinical ED pharmacist?” “What can a pharmacist uniquely contribute to the joined up, multi-disciplinary, multi-skilled urgent and acute / emergency care workforce of the future?” Liz Brown BPharm(Hons) DipClinPharm, Emergency Department Pharmacist, East Lancashire Hospitals NHS Trust and Matt Aiello MA LLB (Hons) BA(Hons), Programme Lead, Urgent and Acute Workforce Transformation Health Education England – West Midlands

* Innovations in Cardiovascular Care Using examples from the presenters own clinical practice, this interactive session will highlight innovative pharmacy projects which have shown improved outcomes for patients with or at risk of cardiovascular disease and discuss how clinical pharmacists can develop and deliver innovative projects in their own practice. Helen Williams MRPharmS FFRPS PGDip Cardiol Ipresc, Consultant Pharmacist for Cardiovascular Disease, Southwark CCG and Sotiris Antoniou FFRPS MRPharmS MSc Dip Mgt Ipresc, Consultant Pharmacist, Barts Health NHS Trust

In association with

14:00 14:45

Delivered by Medicines optimisation in mental health: is it different? * Reviewing the evidence base & principles of medicines optimisation, this presentation considers the practicalities of implementation for mental health, whether in general or specialist practice. We will discuss the skill set required and how to acquire & develop these skills Graham Newton BSc(Hons) PGCertClinPharm FCMHP, Principal Clinical Pharmacist Mental Health Services, 5 Boroughs Partnership NHS Foundation Trust

Diabetes update for Pharmacy * The presentation aims to strengthen knowledge on newer classes of diabetes medication and highlight updates on the new NICE Type 2 diabetes guideline. There will be an interactive session for delegates to participate to share their treatment choices on case studies. Michelle Lam, Lead Diabetes & Endocrinology Pharmacist, Hull and East Yorkshire Hospitals NHS Trust In association with

Delivered by Optimising medicines related care for people: Supporting patients with * communication and swallowing difficulties These two presentations will include and overview of these conditions. The dysphagia session introduce the use of newly developed practical guidance, discussing practical and legal implications of swallowing and formulation issues. The aphasia session will introduce visual aids to consultations using the example of anticoagulation. Both sessions will provide opportunity for the audience to ask questions. Nina Barnett MSc FFRPS FRPharmS IPresc JP, Consultant Pharmacist, Care of Older People London North West Healthcare NHS Trust & NHS Specialist Pharmacy Service; Paresh Parmar MSc MRPharmS Ipresc, Lead Pharmacist for Stroke and Care of the Elderly, London North West Healthcare NHS Trust and Satinder Bhandal MSc MRPS DMS IPresc, Consultant Anticoagulation Pharmacist, Pharmacy, Buckinghamshire Healthcare NHS Trust

Paresh Parmar

Are you in the 91%: optimising inhaler technique * Research shows that many people prescribed inhalers are unable to use them probably. It is also known that many healthcare professions also do not know the optimum technique for inhalers – Do you? In this session Anna will provide an overview on the correct way to use and teach people how to use inhalers. Learn the 7 steps to inhaler success! Anna Murphy MRPharmS (IP) Dpharm, Consultant Respiratory Pharmacist, Consultant Respiratory Pharmacist, Cardio-respiratory Directorate, University Hospitals of Leicester NHS Trust In association with

15:00 -15:45 15:00 15:45

Inﬂammatory bowel disease medicines optimisation * IBD is a chronic and potentially debilitating disease and needs to be managed intensively to allow the patients to lead a normal as possible life. There are only a very small number of treatment options available and medication needs to be optimised from the beginning to obtain best outcomes. Anja St Clair-Jones, Lead Pharmacist for Surgery and Digestive Services, Brighton and Sussex University Hospitals NHS Trust In association with

www.pharmacycongress.co.uk

2016 EXHIBITORS AbbVie Abloy UK Accord Healthcare Actavis UK Aegate Aguettant Alium Medical Amgen Alzheimer’s Society Astra Zeneca B. Braun Medical Barts Health Pharmaceuticals BD Medical Biogen Bristol-Myers Squibb Pharmaceuticals Chiesi CIG Healthcare Partnership’s Citysprint Healthcare CoAcS Code4Health Contec Contronics Centre for Postgraduate Pharmacy Education Daiichi Sankyo Denward Manufacturing Distinctive Medical Dr Reddys Laboratories (UK) Ltd Durbin Plc DX Group Eastbourne Pharmaceuticals Econix Esco GB Fitness To Practice Support Fontus Health Fresenius Kabi Galen Glasdon UK Limited GlucoMen GPhC Grunenthal GSK Guild Of Healthcare Pharmacists’ hameln pharmaceuticals HCA International Healthcare at Home Healthnet Homecare Helapet Hospira UK Ltd (now a Pfizer company)

J45 E30 B15 E20 G48 K45 K40 J53 A35 H42 B30 E54 D30 D40 F28 F35 H61 E35 E50 K37 B18 A30 H29 H25 B49 K25 J36 E48 B50 C1 C2 F45 G61 A48 B20 F48 J58 B40 K10 G40 F25 H20 E15 G50 J25 G49 K39 H50

Huddersfield Pharmacy Specials iBin Innovations IDIS Global Access ID Medical Indivior Internis Intrapharm Laboratories ITH Pharma Janssen Kent Pharmaceuticals Kora Healthcare Labcold Ltd LEC Medical Leo Pharma Foundation Logixx Pharma London Teaching Pool Martindale Pharma Mawdsleys Medic Alert

H40 B3 F18 E10 K20 J30 H19 C15 K29 F37 K42 H10 C10 D50 A47 H46 F10 A40 B35

Medication Management Solutions

G64

Medcura Technologies Medisca Micronclean Mistura Enterprise MSD Mylan

J37 J28 E56 B38 C45 D15

Nisus Medical Nitritex Ltd Nova Laboratories Novartis Omnicell Orion Pharma Oxford Pharmacy Stores Pan Pharma Panasonic Biomedical Parkinson’s UK PDA Pharmacist Support Pharmacy Medical Polar Speed Distribution Portsmouth Hospitals NHS Trust

G10 B10 D10 C40 J10 B48 E58 G20 A27 H11 G58 C50 F1 G42 A20

Primary Care Pharmacists’ Association

J20

ProStrakan Pharmaceuticals PSUK Pulse QDEM Quantum Pharmaceutical RDP Solutions RIG Healthcare Recruit Roche Products Rosemont Pharmaceuticals Royal Free Specials Royal Pharmaceutical Society RX Health Rx-info Sanofi Sensible Staffing Shoreline Sintek Ltd Smartway Pharma St. Mary’s PMU Spirit Medical Stockport NHS Foundation Trust Sun Pharmaceuticals (UK) Ltd Teva UK Thame Labs Thornton + Ross Dermatology Torbay Pharmaceuticals Toshiba TEC UK Imaging Systems Ltd Total Assist Truven Health Analytics UKCPA Venner Medical International Vifor Wiley Willach Pharmacy Solutions WinMan Wockhardt UK Written Medicine writtenmedicine.com Your World Recruitment Education Hub Exhibitors CPC4ALL, Keele University Liverpool John Moores University Medway School of Pharmacy Queen’s University Belfast Robert Gordon University University of Manchester Healthcare Learning

B45 F59 A28 E49 F20 J26 G2 J40 H44 A10 G28 G4 A32 K12 K39 A38 G3 F58 D1 C35 B47 F15 F30 H55 J34 G25

KEYNOTE THEATRE Sponsored by:

B50

C50

D50

B50

Leo Pharma

DX Group Pharmacist Support

A48 Fontus Health

B45 B47

A47

Stockport Pharmaceuticals ProStrakan

Logixx

C45 MSD

B48

A40

Orion Pharma

B40

Mawdsleys

Glucomen

SIMULATION WORKSHOPS

D40

Biogen

C40 C49

B49

Willach Novartis Pharmacy Solutions

Denward Manufacturing

2.5

A38 Shoreline Medical Refrigeration

B35 B38

A35 Alzheimer's Society

K35 J60 J50 G12 G52 G45 H49 C49 B1 C30

C35

D30

Spirit Medical

MaPPS

Medic Alert

C30

A32

B30

RX-info

B Braun Medical

BD Medical

Wockhardt

A30 Contronics

B20

CAFÉ

A28 Pulse

Fresenius Kabi

Sponsored by:

E32 E31

A27 Panasonic Biomedical

B E F C D A G

Partners’ Lounge British Oncology Pharmacy Association Neonatal and Paediatric Pharmacists Group HIV Pharmacy Association The Association of Pharmacy Technicians UK The College of Mental Health Pharmacy UK Renal Pharmacy Association UKMi

POSTER ZONE

A20

C15

B15

Portsmouth NHS Trust

Accord Healthcare

A10

Nitritex

WinMan

D10

C10

Contec

iBin

Mylan

ITH Pharma

B10 B18

Royal Free Specials

D15

Nova Labs

LEC Medical

Eastbourne

Econix

D1 St Mary’s PMU

RIG Healthcare

www.pharmacycongress.co.uk

CONGRESS FLOORPLAN

MEDICINES OPTIMISATION WORKSHOPS

Exhibitor Lounge

F60

H61

G61

G60

Communications International Group

Fitness To G64 Practice Support Robotik Technology UK

CLINICAL THEATRE 1

Total Assist

Sponsored by:

F58 Smartway Pharma

E54

E50 CoAcS

Barts

E56

Micronclean

F59

E58

OPS-NHS

PSUK

G52 G58

H52 H55

J53

G50

H50

J50

PDA

Venner Medical Tech

Thame Labs

Amgen

Hospira

HCA Hospitals

Truven Health

J58

Glasdon

K45 Aguettant

E40

Durbin

E49

QDEM

CLINICAL PHARMACEUTICS AND TECHNICAL SERVICES THEATRE Sponsored by

E32

Written Medicine

E35

F45

F48 Galen

Esco GB

Booked

Kent

Chiesi

E31

Your World Recruitment

E30

City Sprint Healthcare

F30

Abloy UK

Rosemont Pharmaceuticals

Abbvie

Kora Healthcare

H49

G49

H40 H42

Healthnet Homecare

Huddersfield Astra Pharmacy zeneca Specials

G40

Grünenthal

F37

F35

K42

J45

Wiley

Polar Speed Distribution

Bupa NETWORKING LOUNGE

TLTP

Vifor Pharma Aegate

G42

F40

H46 H44

G45 G48

Roche Products

J34 Thornton + Ross Dermatology

STRATEGY AND POLICY FORUM

J30

Sponsored by:

Teva UK

K40

J40

Internis

J36

Dr Reddy

Alium

Staffing

K37

Medcura Technologies

Code4Health

Helapet

Sponsored by:

K39 Sensible

J37 J39

CLINICAL THEATRE 2

K35 Toshiba

K29 Janssen

F20

E20

F28 Bristol-Myers Squibb

Actavis UK

Quantum Pharmaceutical

F25 GSK

G25Torbay

H25

Pharmaceuticals

G20 G28 Panpharma

RPS

J25

Daiichi Sankyo

J26

Healthcare RDP at home Solutions

H20 H29 CPPE

GHP

K25 Distinctive Medical

J20 J28 Medisca PCPA

K20

J10

K12

Indivior

PARTNERS’ ZONE

E15 hameln pharmaceuticals

E10 ID Medical

ENTRANCE

F15

F10

Sun Pharmaceuticals Martindale Pharma

F18 IDIS Global Access

F1 Pharmacy Medical

G10 G12 Nisus

UKCPA

H12 Lounge

Sanofi

INNOVATION & TECHNOLOGY FORUM

H11

H19

Parkinson’s UK

H10 Labcold 5

G2 G3

RIG HealthCare Recruit

Sintek

Omnicell

Intrapharm Laboratories

EDUCATION HUB

K10 GPhC

LEADERSHIP THEATRE In Association with:

www.pharmacycongress.co.uk

LEADERSHIP THEATRE

In partnership with:

Rahul Singal Jeannette Howe

Ann Jacklin

FRIDAY 22ND APRIL

SATURDAY 23RD APRIL

09:00 09:45

Consultant Pharmacists: past, present and future The presentation will include a brief description of the department of health guidance and provide an overview of developments from the last 10 years, including achievements of the post. It will include a summary of the current strategy and describe how the role links with RPS faculty, including the role of Consultants as part of leadership team initiating faculty. Information will be provided to support practitioners interested in becoming a consultant and for Chief Pharmacists interested in developing roles Nina Barnett MSc FFRPS FRPharmS IPresc JP, Consultant Pharmacist, Care of Older People, London North West Healthcare NHS Trust & NHS Specialist Pharmacy Service and Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust

10:15 11:00

Hospital pharmacy & medicines optimisation To provide an update on progress with the Hospital Pharmacy & Medicines Optimisation Project part of Lord Carter’s NHS Productivity and Efficiency Programme Ann Jacklin BPharm CHSM FRPharmS, Professional Lead, Department Of Health

13:00 13:45

Lunch symposium: Pharmacy - Critical to identifying, managing and reducing the emerging trend of addiction to opioid analgesics ** An overview of the current workshops being delivered across Scotland, including background, prevalence, an exploration of how to effectively engage with people who may have Opioid Analgesic Dependence and how to support better management and reduction of OAD Annamarie McGregor MRPharmS, Practice Development Lead, Royal Pharmaceutical Society and Duncan Hill MRPharmS, Specialist Pharmacist in Substance Misuse, NHS Lanarkshire Delivered by

14:15 15:00

15:30 16:15

Ravi Sharma

Lelly Oboh

Polypharmacy & deprescribing Based on current UK literature, clinical pharmacist-led approaches and patient scenarios, the presentation will cover 1. Polypharmacy basics: Common terminologies, Causes and Impact 2. Managing polypharmacy as part of overall medicines optimisation strategies: Challenges, Deprescribing, Tools and Strategies 3. A patient centred approach to deprescribing: Consultation, Care planning, Coordination and Collaboration Lelly Oboh FRPharmS IPresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas NHS Trust and NHS Specialist Pharmacy Services and Nina Barnett MSc FFRPS FRPharmS IPresc JP, Consultant Pharmacist, Care of Older People, London North West Healthcare NHS Trust & NHS Specialist Pharmacy Service Rebalancing medicines legislation and pharmacy regulation Update on the Rebalancing Medicines Legislation and Pharmacy Regulation Programme including: • Pharmacy premises standards • Mitigating the criminal offence for dispensing errors • Superintendent pharmacists and responsible pharmacists • Pharmacist supervision Jeannette Howe BPharm MSc MHM FRPharmS, Head of Pharmacy, Department of Health

16:30 17:15

Antimicrobial stewardship – how pharmacists are helping to combat antimicrobial resistance? An overview of the UK AMR strategy highlighting the key areas relevant to pharmacists. How the national stewardship programme has been delivered in Scotland focusing on the leadership roles of pharmacists. The role of the UKCPA Pharmacy Infection Network and the RPS AMR Expert Group. How pharmacists in all settings can contribute to tackling AMR through reducing unnecessary antibiotic use and optimising prescribing. Jacqueline Sneddon MRPharmS FFRPS, Project Lead, Scottish Antimicrobial Prescribing Group, Chair of Pharmacy Infection Network, UKCPA, Healthcare Improvement Scotland

17:30 18:15

Quality standards – a lost cause? Since its inception over 60 years ago the NHS has experienced multiple reorganisations. It is subject to continual scrutiny, reviews and inspection. There is an industry developing and issuing good guidelines and standards, and clearly significant improvements have been made and we can be proud of the health service that we have. The question remains, could we do better? Is this top down approach to imposing quality as effective as it could be? Anthony Sinclair BSc MSc FFRPS FRPS, Chief Pharmacist, Birmingham Children’s Hospital NHS Foundation Trust and Parisa Mirbod MPharm MRPharmS, Lead Quality Assurance Pharmacist, Birmingham Children’s Hospital NHS Foundation Trust

10:15 11:00

11:30 12:15

Assuring the pharmacy workforce Pharmacy services are at a time of transformational change. There is a developing evidence base to substantiate the emerging roles for pharmacists. To deliver on the exciting opportunities to improve patient care the pharmacy profession needs a workforce that is fit for purpose. It needs to provide the public and other professionals with the confidence that pharmacy can deliver on this agenda. The RPS Faculty is a key element for doing this. The barriers and enablers need to be understood and addressed. Howard Rowe FFRPS FRPharmS, Clinical Director: Head of Medicines Management, Cwm Taf University Health Board Experiences of the first Clinical Fellow for Pharmacy Share experiences and learning of a unique opportunity to spend time in a national healthcare-affiliated organisation outside of clinical practice to develop skills in leadership, management, strategy, project management, and health policy. Will share the journey of the fellowship from why I applied, what I have done to what I have learnt and next steps. I will discuss the implications of the fellowship on leadership development within the profession and wider healthcare. Rahul Singal MFRPSI MRPharmS PG Dip GPP, Clinical Fellow, NHS England In association with

12:45 13:30

Lunch Symposium: Value and outcomes in Type 2 diabetes Marc Evans, Consultant Endocrinologist, Cardiff

Delivered by

14:00 14:45

New standards for all pharmacy professionals; upholding confidence delivering safe and effective care The General Pharmaceutical Council (GPhC) plans a major consultation this spring on standards for pharmacy professionals, which will help deliver safe and effective health care and uphold trust and confidence in pharmacy. GPhC Chair Nigel Clarke will discuss the organisation’s approach and goals in the development of the new draft standards and how they will help pharmacy professionals deliver on the promise of person-centred care every patient has a right to expect. Nigel Clarke, Chair, General Pharmaceutical Council In association with

15:00 15:45

New roles – care homes and GP surgeries Medicines management is often poor with residents being prescribed medicines at are appropriate, without review and rarely involving residents. This session will share learning from the Northumbria Shine project. During the session the audience will learn about a pragmatic ‘3 questions’ approach to assessing appropriateness for each medicine prescribed and how to share decisions about prescribing with residents and/or their families. We will discuss the the various interventions pharmacists can make including deprescribing and show how pharmacist prescribers can lead this process. Ravi Sharma, Head of Primary Care Integration and Lead GP Practice Pharmacist, Green Light and Honeypot Medical Centre and Wasim Baqir, Research and Development Pharmacist, Northumbria Healthcare Trust

www.pharmacycongress.co.uk

STRATEGY AND POLICY FORUM

Sponsored by:

Steve Graham Aamer Safdar

Gill Eddy

Nina Barnett

FRIDAY 22ND APRIL

10:30 11:00

12:45 13:30

SATURDAY 23RD APRIL

Educating and training the clinical pharmacy workforce A number of recently published strategic papers in health have set the context for a number of policy initiatives that together, mark a tipping point for the development of the clinical pharmacy workforce. Implementation of the NHS Five Year Forward View and Carter Review mean that most pharmacists will become prescribers; undertake clinical consultations and use clinical examination skills and make clinical decisions in the next decade. This presentation will set out some of the steps that Health Education and the Centre for Pharmacy Postgraduate Education are working with the GPhc and RPS and others, an initiative in preparing the workforce for this critical change in practice. Sue Ambler FRPharmS Bpharm, Head of Education and Training, Health Education England Lunch symposium: Driving a better homecare experience for patients through small, continuous improvements ** A session to explore how incremental improvements to operations can have a significant impact on productivity, patient safety and experience Susan Gibert, Homecare Medicines Pharmacist, Thames Valley and Wessex Pharmacy Procurement Service; Stephen Cook, Director of Pharmacy and Quality, Bupa Home Healthcare and Alan Davey, Director of Operations, Bupa Home Healthcare

10:00 10:30

11:00 11:30

In association with

14:45 15:15

12:00 12:30

In association with

15:30 16:00

The Registration Assessment – 2016 and beyond The session will explain the rationale for changing the Registration Assessment from 2016 and will outline the main changes. The coverage of the Registration Assessment will be explained by examining the new Registration Assessment Framework in depth. The two parts of the new style Assessment will then be discussed in depth. Damian Day, Head of Education, General Pharmaceutical Council

16:15 16:45

17:00 17:30

17:45 18:15

14:00 14:30

In association with

The challenges of safe and efficient supply of MS disease-modifying drugs * The number of disease modifying therapies for Multiple Sclerosis is ever growing and this is has led to its own complications in terms of supply. How do you manage the ongoing supply of the medication whilst ensuring it is safe, monitored and avoids waste for the NHS? Joela Mathews MPharm MFRPSII PG Cert HCl (Open), Highly Specialist Pharmacist: Neurosciences and Service improvement, Barts Health NHS Trust In association with

NHS eProcurement strategy – update Steve Graham, eProcurement Lead at the Department of Health, will present an overview of the NHS eProcurement strategy published in May 2014 and update on progress made so far. Steve Graham, CIPS, eProcurement lead, Department of Health NHS Specialist pharmacy services: policy update Justine Scanlan, Head of Specialist Pharmacy Service, NHS England

Antimicrobial stewardship – making it happen The threat that resistance to antimicrobial agents could mean that in the future common infections cannot be treated is of great concern to us all. Pharmacists are well placed to inform and educate both healthcare professionals and the public about antimicrobial resistance, and how to reduce its effect. This session will explore how this can be achieved by:1. Helping patients understand when antibiotics should be used appropriately, and when they should not be used 2. Supporting people who may be at increased risk of harm due to antibiotics medicines, for example older people 3. Putting good systems in place to reduce antimicrobial resistance 4. Using alternative strategies to immediate prescribing for self-limiting conditions 5. Working across organisations to support antimicrobial stewardship 6. Supporting people to manage their own care for self-limiting conditions Gill Eddy BPharm MSc MRPS, NICE Medicines Prescribing Programme Regional Technical Adviser (East, Midlands and Wales), NICE and Zoe Girdis BPharm MPRPS PIP Diploma Clinical Pharmacy, NICE Medicines Prescribing Programme Regional Technical Adviser (South of England and Channel Islands) and Pharmacist Independent Prescriber, NICE In association with

In association with Health and justice pharmacy practice • The background about pharmacy services and medicines optimisation in secure environments • Update on the faculty- strategy and knowledge guides and how we plan to use this approach to develop a handbook for the health and justice sector Denise Farmer MRPharmS, Pharmaceutical Adviser Health and Justice Commissioning, NHS England (Central and East Anglia Area Team) and Stuart Semple MSc MRPharmS, Faculty Development Executive, Royal Pharmaceutical Society

Workplace challenges: Tutor support * This session will present an innovative, light weight but not light touch, course for workplace tutors which has been accredited by the RPS. The King’s Health Partners Statement of Teaching Proficiency is one such course. Aamer Safdar BPharm (Hons) MSc PGCE MA FHEA FFRPS MRPharmS, Principal Pharmacist Lead for Education and Development, Guy’s and St Thomas’ NHS Foundation Trust In association with

An update on medicines information and support for medicines optimisation * Sue Dickinson, Director of Pharmacy, Regional Drug and Therapeutics Centre and current Chair, UKMi

Digital medicines strategy The presentation will outline the current position as regards the work underway to deliver the National Information Board framework and other work relating to ePrescribing/digital medicines in relation to medicines optimisation and the drive towards becoming paperless. Update on national digital strategy: • N.I.B strategy • Digital maturity work • Digital road maps Ann Slee, ePrescribing Lead, NHS England

Expanding the general practice pharmacist role Introduction to the GP opportunities for GP clinical pharmacists. Describe the enabling support required to develop roles and avoid isolation in new roles. Outline NHS context, current strategy and future aims for GP clinical pharmacist roles. Describes examples of learning and support for new GP clinical pharmacist roles including CPPE learning pathway designed to develop patient facing patient care in general practice. Ravi Sharma, Head of Primary Care Integration and Lead, GP Practice Pharmacist, Green Light and Honeypot Medical Centre and Ceinwen Mannall, National Lead, General Practice Pharmacist Training Pathway, Centre for Pharmacy Postgraduate Education In association with

Delivered by

14:00 14:30

Sue Ambler

14:45 15:15

Cancer medicines. Making the unaffordable affordable through medicines optimisation * Rob will be discussing the ways in which medicines optimisation can help in supporting access to medicines, in a climate where demand is increasing and we are confronted with new advances in therapy at an ever increasing rate. Robert Duncombe MSc BPharm(Hons) MRPharmS, Director of Pharmacy, Christie NHS Foundation Trust In association with

Join the conversation! Tweet us!

@CPCongress #CPC16

www.pharmacycongress.co.uk

INNOVATION & TECHNOLOGY FORUM

Wasim Baqir Philip Dean

Dave Buller

FRIDAY 22ND APRIL

10:00 10:30

10:45 11:15

12:45 13:30

SATURDAY 23RD APRIL

A simple journey of a medicine in hospital: from the medicine’s perspective! Medicines are complex interventions that influence health outcomes. The current age of digitalisation, adds a layer of complexity that is not always recognised when it comes to optimising medicines use and safety. This presentation will highlight some of these complexities and consider implications for practice. Yogini H Jani BPharm (Hons) MSc PhD FFRPhS, Medication Safety Officer, UCLH NHS Foundation Trust

09:00 09:45

Refer-to-pharmacy: Making it work in practise The presentation includes: • Why Refer-to-pharmacy was conceived • The beneﬁts of community and hospital pharmacy working together • A live demonstration of the system! • Performance & outcomes since Refer-to-Pharmacy went live • How to get Refer-to-pharmacy into another health economy • Additional support to facilitate the introduction of Refer-topharmacy into another health economy Alistair Gray MRPharmS BSc(Hons) DipClinPharm, Clinical Services Lead Pharmacist, East Lancashire Hospitals NHS Trust

Lunch symposium: Automating medication dispensing to drive efficiencies ** Find out how something as simple as replacing traditional drugs cabinets with automated dispensing cabinets and systems really does offer hospitals a great opportunity to improve the way they work, save money and staff time and improve patient safety – helping Trusts to achieve many of the recommendations outlined in Lord Carter’s recent report. Learn about one hospital’s automated medicines management journey and the way it’s making a difference to patients and staff. David Buller UK&I Sales Director, Omnicell; Philip Dean, Head of Pharmacy & Quality Control Laboratory Services, North Tees and Hartlepool NHS Foundation Trust and Philip Dean MPharm MRPharmS GPhC, Head of Pharmacy & Quality Control Laboratory Services, North Tees and Hartlepool NHS Foundation Trust Delivered by

14:00 14:30

Yogini H Jani

Shaun Powell

Connecting patients to medication through technology Darren Taylor and Justin Moore from CitySprint Healthcare, have teamed their wealth of delivery experience with their Healthcare Industry expertise, to look at how delivery has changed so many industries over the past few years and why Healthcare needs to catch up. The presentation will focus on the importance of track and trace technology within hospitals and for delivery medications to homes, as well as identifying key areas within the pharmaceutical industry that could be enhanced through delivery. Justin Moore, Sales and Marketing Director, CitySprint and Darren Taylor, Logistics Director, CitySprint

Delivered by

10:15 10:45

15:00 15:30

15:45 16:15

Comparing hospital medicines use The presentation will cover the drivers for comparing hospital medicines use including the rising trend in hospital prescribing costs and the recent Carter report. The barriers and challenges to comparing hospital medicines use will be discussed and available hospital medicines usage data sets. The presentation will then consider how comparative data can be used to support improved quality and safety in prescribing, as well as opportunities for financial savings, all supported by real life examples. Ray Fitzpatrick BSc PhD FFRPS FRPharmS, Professor of Clinical Pharmacy, School of Pharmacy, Keele University

16:30 17:00

Making time - giving patients with a learning disability time helping them understand their health and how to keep well The “Making Time” project is to try and make sure people with learning disabilities get the best service they can from their community pharmacy. It’s about making sure that pharmacy services can offer the kind of person centred service that people with a learning disability really need to stay safe and well. The Making Time project is based on a year of care approach which is about a proactive process of planning the care and services offered to patients with improved patient involvement, a personalised approach which supports self-management. Nigel Hughes, Public Health Specialist, Community Pharmacy West Yorkshire

17:15 17:45

Pharmacists embedded in the ward MDT - the Colchester ward intern pharmacist project In a pioneering project, two pharmacists have been appointed on each of two wards as members of the ward staff establishment. They are performing a mix of traditional pharmacy activities and medicines-related tasks traditionally carried out by nurses. This presentation will review the progress and challenges experienced so far in this developing initiative. Richard Needle BPharm PhD CHSM FRPharmS, Chief Pharmacist, Colchester Hospital University NHS Foundation Trust

Innovation within Antimicrobial stewardship Innovative antimicrobial stewardship strategies will be discussed, using examples from Hinchingbrooke NHS Trust and the East of England Pharmacy Infection Network. Topics that will be covered are; antibiotic related CQUINs for 2016/2017, the future of antimicrobial stewardship and up and coming publications regarding antimicrobial stewardship. Emma Cramp MRPharmS MSc MFRPSI, Advanced Clinical Pharmacist - Infection Management, Hinchingbrooke NHS Trust In association with

11:15 11:45

12:15 12:45

14:00 14:30

Delivered by GS1 – the stripy glue – Joins up medicines and their safe use in healthcare GS1 is the coding standard that is being introduced for all NHS products, locations, staff and patients to allow data on use of products to be captured and analysed. This includes medicines and links closely with systems such as dictionary of medicines and devices (dm+d) and the EU Falsified Medicines Directive. Andrew Davies FRPharmS, Director of Pharmacy, North Bristol NHS Trust

Breakfast symposium: Increasing nursing efficiency and medicine management security using intelligent locking ** This presentation explains how Abloy’s unique PROTEC2 CLIQ electro-mechanical lock system can be incorporated into new or existing drug cabinets to release valuable nursing time back into patient care. It is simple and cost effective to install to a variety of drug cabinets from CD cabinets, POD lockers and mobile drug trolleys to bedside patient lockers. The system also offers tight control around keys used for drug cabinets including audit trail information on locks and keys. Shaun Powell, General Sales Manager, ABLOY UK

14:45 15:15

Pharmacist prescribing - current challenges, issues and opportunities Wasim Baqir, Research and Development Pharmacist, Northumbria Healthcare Trust The new Chief Pharmacist Development Programme The NHSE Chief pharmacist development programme, designed and delivered in partnership between CPPE and the NHS Leadership Academy, will equip new in-role and aspiring chief pharmacists with the necessary knowledge, skills, behaviours and experience to effectively perform this senior role. The 12-month fully funded programme offers a comprehensive mix of residential training, specialist study days, mentoring, online self-directed study, assessment and support. Karen Wragg MRPharmS, Regional Manager South Central, Centre for Pharmacy Postgraduate Education Steps to pharmacy heaven Summary of how IT systems can be brought together to benefit pharmacy, from the clinical pharmacy team, to streamlined ways of medicine ordering/supply and use of electronic controlled drug ordering. Alex Jennings, Deputy Chief Pharmacist, Aintree University Hospital Coding the future An introduction to the work of the Code4Health Pharmacy Community. What role can pharmacy play in the shaping the future of digital technologies that intersect at the point of greater patient empowerment, data, and digital disruption? The presentation will outline the challenges facing healthcare, the current constraints and why we need to think and act differently to achieve the healthcare system of the future. Coding, open source and the future of pharmacy itself. Mohammed Hussain FRPharmS, Medicines Digital Strategy team, NHS England In association with

15:30 16:00

The secondary use of data for medicines management Optimal Medicines Management strategies require us to provide rational, effective and cost effective treatment to groups of patients. Increasingly with the use of electronic health records alongside the data captured for primary use, we get secondary access to ‘big data’ on medicines use. But it takes some effort to convert big data into useful information. Using relevant examples this presentation will explore the use of secondary data capture for medicines management looking at the benefits and challenges in practice. Jamie Coleman MBChB MD MA (Med Ed) FRCP FBPhS, Professor in Clinical Pharmacology and Medical Education, University of Birmingham

www.pharmacycongress.co.uk

CLINICAL PHARMACEUTICS AND TECHNICAL SERVICES THEATRE

Sponsored by:

NEW!

Orlando Jaquez David Graham

Laura McEwen-Smith

Jackie Eastwood

FRIDAY 22ND APRIL

10:15 11:00

SATURDAY 23RD APRIL

Handling of monoclonal antibodies and vial sharing updates to guidance * To give an overview of the history of monoclonal antibody handling guidance and why an update was felt to be overdue. To run through the considerations for handling monoclonal antibodies within healthcare including health and safety and other risk factors. To summarise the guidance on vial sharing and how this fits into the medicines optimisation agenda. Mark Santillo, MRPharmS, Regional Quality Assurance Officer, Torbay and South Devon NHS Foundation Trust

10:00 10:45

14:15 15:00

Lunch symposium: Quality standards in specials

Delivered by Clinical Applications of Radiopharmaceuticals – Not part of my Pharmacy Practice – or are they? Brief Summary of Radiopharmacy Practice; types of diagnostic imaging & standard views; the bone scan – imaging metastatic spread; the renal scan – imaging renal function; myocardial perfusion imaging – imaging angina; cerebral perfusion imaging – imaging dementia; Positron Emission Tomography (PET) – imaging cancer David Graham BSc MSc MRPharmS GPhC, Radiopharmacy Team Leader, Aberdeen Royal Infirmary, Research Fellow, John Mallard Scottish PET, Centre NHS Grampian & University of Aberdeen In association with

15:15 16:00

11:00 11:45

12:00 12:45

Risk management of medicines stored in clinical areas : Temperature control * Richard Bateman MRPharmS, Quality Assurance Specialist Pharmacist, East and South East England Specialist Pharmacy Services

17:30 18:15

The structure of Medicines Procurement nationally and regionally across England and how it underpins the Medicines Optimisation agenda This presentation will explain how medicines are contracted for across England and how Medicines Optimisation and Pharmacy Procurement Specialists work with both NHS England and CCG commissioners , providers and other stakeholders in delivering cost effectiveness and value to patients. Clinical Medicines Procurement is a key driver in reducing costs and examples will be included in the presentation of how consensus amongst clinical stakeholder groups can change market shares of medicines. In addition the presentation will cover the use and uptake of biosimilars and highlight the benefits of these new innovative medicines to patients Phil Aubrey, LPP Medicines Optimisation and Pharmacy Procurement Secondary Care Lead, London Procurement Partnership How can we be assured of the quality of aseptic preparation services within the NHS? This session will explain the safeguards that are in place to assure clinical pharmacists that aseptically -prepared injectable medicines such as parenteral nutrition, cytotoxic reconstitutions, and other central intravenous additives prepared in NHS pharmacies are safe for patients. The speaker will give an overview of the national quality standards and audit programme that are in place. Alison M.Beaney, Regional Quality Assurance Specialist, North-East, Chair NHS Pharmaceutical Quality Assurance Committee and Visiting Professor, University of Sunderland In association with

NEW FOR 2016!

Radiopharmacy: a viable opportunity for hospital pharmacy to implement pharmaceutics, pharmacology and radio chemistry A large amount of pharmaceuticals are used daily in diagnostic medicine, and radiopharmaceuticals (and their production) form an exciting specialty of pharmacy which aids the production of diagnostic, therapeutic and research medicines. Neil Hartman BPharm MSc PhD, UK Radiopharmacy Group Committee and Head of Radiopharmacy, Barts Health NHS Trust In association with

In association with

16:30 17:15

Risks associated with the outsourcing of aseptic preparation * There is an increasing trend to outsource some or all of Trusts requirements for aseptically prepared products. In order to do this safely one must understand the risks associated in this process and ensure systems are in place locally to mange them. Richard Bateman MRPharmS, Quality Assurance Specialist Pharmacist, East and South East England Specialist Pharmacy Services In association with

In association with

12:45 13:30

Richard Bateman

12:45 13:30

Pharmacy Technicians: Are your consultations skills good enough? The modern world of pharmacy practice and the evolving roles of pharmacy professionals means that pharmacy technicians are spending more time than ever conducting patient consultations. Taking a true patient-centred approach to the consultation requires skill and practice – this presentation will introduce pharmacy technicians to communication techniques and resources to support them in developing the consultation skills needed now and in the future in providing high quality care to patients. Laura McEwen-Smith APharmT, CPPE Local Tutor, Centre for Pharmacy Postgraduate Education Lunch symposium: Manufacturing matters: The science behind biosimilars of advanced Biologics ** This presentation will discuss the manufacture of biosimilar versions of advanced biologics. It will illustrate the critical importance that the quality and robustness of the manufacturing process plays in the development of these molecules. Further, it will show that identification of critical quality attributes at the molecular level is the essence of developing a molecule that is highly similar to the originator in the clinical setting. Orlando Jaquez MA BM BCh PhD FRCP FRCPE, Senior Program Manager, Medical Affairs, Biosimilars, Biogen Delivered by

14:00 14:45

14:45 15:30

Clinical trials - a career pathway as a research pharmacist? The clinical trial presentation will have skills needed for becoming a clinical trials pharmacist and the career path of a trial pharmacist, what does a trial pharmacist do, what’s new in trials. Anna Song, Regulatory Manager Pharmaceuticals, UCL

Quality management and governance of homecare contracts * Homecare is an increasing cost to the NHS, with more patients receiving care in this fashion and more therapies using homecare services. This presentation will cover the governance required to manage homecare contracts and monitor the homecare companies, to ensure patients receive a safe and effective treatment, and that the NHS is getting value for money. Jackie Eastwood BSc (Hons) GPhC, Outsourced Medicines Co-ordinator London Region, London Pharmacy Procurement In association with

The Clinical Pharmacy Congress has expanded to include content relevant to pharmacy professionals working in quality assurance, quality control, radio-pharmacy, aseptic services, production and manufacturing as well as procurement services and clinical trials. Programmed in partnership with the Technical Specialist Education and Training group (TSET) and the Radiopharmacy Group. The Technical Specialist Education and Training group are an NHS committee actively supporting and promoting the work of NHS staff working in the technical aspects of hospital pharmacy. Tess Fenn, chair of the Association of Pharmacy Technician’s (APTUK) says: “For the technical workforce, this is a positive step forward, particularly for pharmacy technicians and pharmacy assistants, who may not immediately recognise their role in the principles of clinical pharmaceutics and improving patient outcomes.”

www.pharmacycongress.co.uk

HealthNet Home Care

Polar Speed, a UPS® company

HealthNet Homecare (HealthNet) is a company born from one vision; that Homecare and direct to patient (DTP) services can and should be delivered in a better way. Our belief is that we can and will provide services that add greater value, that are designed around the needs of patients, in line with the priorities of the NHS and our Pharmaceutical partners.

There is a revolution taking place in healthcare delivery. Patient-centered care is changing the way that professionals think about health and its management, which is reshaping the NHS, healthcare organisations and their funding structures. The revolution is all about putting patients and their individual needs at the centre of healthcare systems. The potential benefits of this transformation are enormous - but none of them can be delivered without a matching revolution in intelligent, data-rich logistics.

The HealthNet team have worked closely with the NHS to help build and develop the range of homecare services that patients benefit from today. We have delivered homecare and wholesale services in more than 30 different complex and challenging disease areas over the past 20 years. HealthNet have GMP licensed manufacturing facilities and are able to support the manufacturing (compounding) requirements of our partners. We believe the future of patient care will be increasingly delivered in the community and will be enabled through partnerships with the NHS and Pharmaceutical companies. We support the NHS and Pharmaceutical companies in managing the clinical pathway for patients in out of hospital settings, delivering convenience and choice for patients whilst ensuring value for money. Our programmes are individually tailored to meet the specific patient and customer requirements including purchase and consignment stock models.

Our services: • Pharmacy operations – storage and dispensing of medication • Distribution – direct to patient / hospital / pharmacy • Governance – PV, ADR, AE’s reporting • Invoice processing and payment collection • Patient Services – patient / customer registration and activity coordination • Evidence based adherence, persistence and engagement solutions • Real World Data solutions – compliance / outcomes

The need for complex logistics support, such as clinical homecare solutions are reminders that personalised medicine requires a multi-faceted approach from professionals in many disciplines. Patient empowerment and engagement is key to realising the promise of patient-centred healthcare. The companies that understand this are beginning to take the most important role of all in modern medicine. These are the companies that will do the most to make patient-centered care the pattern of the future. With UPS/Polar Speed, that future is already becoming a reality.

Improve the lives of Patients We believe in working together in the interest of patients. We are committed to working with the NHS, our manufacturer partners, other healthcare professionals and patients to improve the delivery of healthcare and achieve the best health outcomes for people in the UK.

Polar Speed - United Problem Solvers Every member of the UPS/Polar Speed healthcare team understands how important it is to deliver the right medicine to the right patient at the right time, in the right condition. Better healthcare logistics and stronger networks ultimately lead to better patient outcomes. Our logistics and clinical services get your product to market swiftly, safely and securely. This is vital to the well-being of a growing global population. We have market leading solutions, and know-how to help you improve the delivery of healthcare and best patient outcome in the UK. So why go it alone? Turn to the experience, expertise and network of UPS/Polar Speed.

It’s a Patient, not a Package

VISIT US AT STAND G42

HealthNet’s mission is to be the partner of choice for Pharmaceutical companies, the NHS, patients and their families, but this can only be achieved by developing the right solutions that add value, empowering patient choice and offering flexibility. HealthNet’s solutions are therefore based on delivering value, quality and convenience to all stake holders.

VISIT US ON STAND G49

NEW PRODUCT COMING SOON!

FONDAPARINUX Good Health Can’t Wait. Dr. Reddy’s Laboratories (UK) Ltd. is an integrated pharmaceutical company committed to accelerating access to affordable and innovative medicines because we believe Good Health Can’t Wait. Prescribing Information: Refer to full Summary of Product Characteristics before prescribing. Information about this product, including adverse reactions, precautions, contraindications and method of use can be found at www.medicines.org.uk/emc/ Indications: See SmPC for full information on the indications. Fondaparinux sodium 2.5mg/0.5ml: Prevention of VTE in adult patients undergoing major surgeries, at high risk for VTE and who are immobilised due to acute illness. Fondaparinux sodium 5mg/0.4ml, 7.5mg/0.6ml and 10mg/0.8ml: Treatment of adults with acute DVT and treatment of acute Pulmonary Embolism, who require thrombolysis or pulmonary embolectomy. Legal category: POM. Marketing Authorisation Holder, from whom full prescribing information is available: Dr. Reddy’s Laboratories (UK) Ltd., Riverview Road, Beverley, HU17 0LD, Tel: 01748 828873 Date of preparation/last revised: February 2016 DRL163 Feb16

First generic fondaparinux solution for injection, pre-filled syringe

Expertise in injectables

• Suitable for self-administration • Needle safety device • Coloured plungers for easy identification • Available in four strengths

Visit us at stand G20 A new injectable supplier to UK hospitals

For information please contact Customer Services T: 01482 389858 E: customerserviceuk@drreddys.com www.drreddys.com

0151 556 1984 info@panpharma.uk

www.panpharma.eu

www.pharmacycongress.co.uk

Medicines Management: Reassurance and peace of mind, Enhancing patient and staff safety Medication in healthcare settings must be stored and dispensed safely and disposed of securely in accordance to the section 13 of the Health and Social Care Act. The CQC recommend that all drug enclosures must never be left open and unattended, and must be in constant supervision by staff. This is very difficult to achieve in practice and the CQC routinely report failings during inspections. If drug enclosures are left open and unattended, this leaves medication vulnerable to theft or tampering by any person in the vicinity, posing major risks to patients and staff. The DruGuardian™ device protects both patients and staff. It is designed to prevent drug theft and tampering and ensures staff comply with the CQC guidelines of never leaving the drug trolley open and unattended.

encourage staff to always perform their job correctly. The device also acts as a deterrent to malicious tampering or medication theft, a problem that costs the NHS millions annually. The regional study, supported by the Eastern Academic Health Science Network showed a 20 fold improvement of correct practice of never leaving drug trolleys open and unattended. It has independently been shown to be cost saving to individual institutions. This session details the clinical work and development of the drug guardian and the results of the AHSN supported regional study. It offers attendees a credible solution to these difficult problems in the NHS - theft, addiction and tampering. Qualitech Healthcare distribute DruGuardian™ in the UK.

thanks to MedicAlert MedicAlert is a UK charity that speaks for its members when they can’t, via our membership service and custom-made medical ID jewellery. As part of our application process we create individual and comprehensive personal records, not only limited to medical information, which include personal details, emergency contacts, GP details and any hospitals or clinics members may be attending as an outpatient.

Our service is unique – by wearing our ID jewellery, emergency professionals have the ability to gain vital information from members’ emergency records, 365 days a year. This also ensures they can confirm the information provided is up-to-date and accurate. The annual membership includes the expertise of MedicAlert’s dedicated team of nurses, who safeguard that each members’ jewellery and electronic record note the most critical information. This in-house support sits alongside an international emergency telephone number, available 24/7, 365 days a year, manned by the London Ambulance Service, who can relay individual details in more than 100 languages.

A grass roots innovation developed by front line clinicians, DruGuardian™ provides a solution to these clinical problems. DruGuardian™ resides inside the drug enclosure and works by acting as a behavioural modifier and uses human factors design principles to

The ID jewellery - situated on a members pulse points - displays an internationally recognised medical symbol to help emergency professionals quickly confirm members’ medical or emergency details and provide fast, effective treatment. MedicAlert provides a fantastic range of ID jewellery options too. Skilled jewellers and craftsmen work to create custom-made designs in stainless steel, fabric wrist bands, silver and gold to suit all budgets and lifestyle requirements.

VISIT US ON STAND G52

For more information about this unique service or to meet some of the MedicAlert team come and visit us on Stand B35 at the Clinical Pharmacy Congress Show.

Tapclob® (clobazam)

The isolator optimized for your application

Clobazam oral suspension

Visit Esco GB at Booth No.: F45

pharmacycongress.co.uk

Tapclob® is indicated as an adjunctive therapy for the treatment of epilepsy. Prescribers are recommended to consult the Summary of Product Characteristics before prescribing Tapclob®. Information about this product, including adverse reactions, precautions, contra-indications and method of use can be found in the Summary of Product Characteristics, available at: www.medicines.org.uk/emc

Containment Barrier Isolator Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Martindale Pharma. Tel: 01277266600. Fax: 01708 382739 e-mail: drugsafety@martindalepharma.co.uk Pharmacy Compounding (Chemotherapy / TPN) | As a Class III Cabinets for Biosafety Levels (BLS) 3 and 4 | Small Batch Sterility Testing | Small-scale Potent Material Handling | Cell Processing | Aseptic Processing | Research and Development Legal Category: POM Martindale Pharma; Bampton Road, Harold Hill, Romford, Essex, RM3 8UG. CRIT/01/2016/415 Date of Preparation January 2016.

13605TW Tapclob 128x176 Advert_v1.indd 1

PLATFORM SPECIALIST.

25/02/2016 12:37

Unit 9, Century Networkcentre, Dearne Lane, Manvers, Rotherham, South Yorkshire, S63 5DE. Tel.: +44 (0) 1709 761 669 • Email: egb.info@escoglobal.com

www.pharmacycongress.co.uk

Bupa Home Healthcare is a leading provider of high quality home healthcare services supporting over 35,000 patients across the UK. We work in partnership with the NHS, pharmaceutical companies and private medical insurers to support patients with a range of treatments and conditions including Home Parenteral Nutrition, Chemotherapy, IV antibiotics, Rheumatoid Arthritis, Multiple Sclerosis, Enzyme Replacement Therapy. Bupa Home Healthcare manages the complete end-to-end home healthcare process, using our in-house facilities and network of highly skilled professionals. More than 1700 patients took part in our annual patient satisfaction survey in 2015. Once again we are delighted to see high levels of patient satisfaction.

Overall quality*

Bupa Home Healthcare

Delivering outstanding healthcare in the comfort of our patients’ homes

92%

of patients said they are likely1 to recommend Bupa Home Healthcare to friends and family if they needed similar care or treatment.

Home delivery*

94%

of patients told us the overall quality of the delivery service is “excellent” or “very good”.

Nursing service*

93%

of patients said the training provided, the clarity of instructions and professionalism of our nurses was “excellent” or “very good”. *2015 Patient Satisfaction Survey Results. 1. “extremely likely” or “likely” to recommend

Come and talk to us in the Bupa Networking Lounge, near the Policy and Strategy Forum area

‘Pouching improves medication management, reduces my process costs and is much safer for my patients. Medication errors go down to zero’

Unit dose packaging for hospitals • • • • •

HD Medi

Medication sorted per administration time Eliminates chance of dispensing errors Easy to use for all pharmacy staff Cost and time savings Improved efficiency and profitability

George Ramsay Nursing Home Dr. Jones Sunday

Ward 5, Room 2

8:00 AM

27-03-2016

Ibuprofen 400 mg tabl. Tablet round pink

Omeprazole 20 mg caps. Capsule white/yellow

Total 2

INTIPharm is a state of the art automated cabinet system. A modular system that can be fully customized to cater for the needs of the central pharmacy, the OR or any other ward. INTIPharm assists in dispensing meds and supports the pharmacy workflow.

HD Medi 560304_advertentie_CPG_01.indd 1

www.hdmedi.eu

info@hdmedi.eu 02-02-16 09:52

www.pharmacycongress.co.uk

FREE NETWORKING RECEPTION

As The Clinical Pharmacy Congress moves into its 5th year we are delighted to announce the Poster Zone at this year’s Congress will return bigger and better than in 2015. The Poster Zone will continue to celebrate and provide a format for individuals and teams within the pharmacy profession to share best practice and network with colleagues from across the UK. Located on the exhibition floor it will display posters submitted by pharmacy professionals from NHS Trusts, private health care, prisons, care homes and many more we will also welcome a limited number of industry colleagues applications. The posters will showcase work, both completed and on-going. There will be four sessions in 2016 with more work displayed in each:

Friday 22nd April, 18:15 -19:30

Session A: Friday 9:15 – 11:15, Session B: Friday 14:30 – 16:30, Session C: Saturday 9:45 – 11:45, Session D: Saturday 13:30 – 15:30

The Congress once again will host a FREE networking reception, this year hosted in The Bridge in the boulevard of ExCeL London. The Bridge restaurant diner and bar will be the perfect venue to continue networking with your pharmacy colleagues after a busy day of learning!

All abstracts will be made available online prior to the Congress and as downloadable PDFs for your smart phones and tablets.

there’s a better place to get better Healthcare at Home delivers the same standard of care your patients would get in hospital, but in the sanctuary of their own home. hah.co.uk

Find out more at booth

J25

LEARN WHILE YOU LUNCH

JOIN OUR SYMPOSIUM

“Quality Standards in Specials” Optimising quality and patient safety in unlicensed medicines

With a special guest speaker, plus experts from Quantum Pharma Group companies UL Medicines and Quantum Aseptic Services

12.45pm – 1.30pm on 22nd April 2016 Clinical Pharmaceutics and Technical Services Theatre

Visit stand F20 Call 0800 112 3363 Register www.pharmacycongress.co.uk

www.pharmacycongress.co.uk

Truven Health Micromedex® Trusted Clinical Evidence Quick Answers

Trusted Evidence

Micromedex Support

Local Content

Access Anytime, Anywhere

Durbin your first stop for ALL imported unlicensed medicines NHS Audited No minimum order value Quality-assured products Risk Management Full technical information support Translation Service Next day delivery of most stock lines

Combined with Powerful Solutions for Clinical and Operational Performance Improvement. Improved Efficiency Enhanced Patient Safety Cost Reduction

Visit the Micromedex experts at the Truven Health booth J50 at the Clinical Pharmacy Congress to learn more, or contact micromedex@truvenhealth.com.

Unlicensed ‘named patient’ medicines | UK discontinued products | UK supply shortages | Orphan drugs

imports@durbin.co.uk | 020 8869 6555 | www.durbin.co.uk

0549650

www.pharmacycongress.co.uk

2016 PHARMACY CONGRESS ‘MUST SEE’ EXHIBITORS

ROBOTIK TECH

DURBIN

VISIT US ON STAND G64

Durbin supplies the following categories of medicines: • UK discontinued products • UK supply shortages • Orphan drugs • Imported Unlicensed/‘named-patient’ medicines

VISIT US ON STAND E48 T+R Zeroderma®Emollients The Zeroderma range of emollients offers similar products to leading emollient brands with cost savings up to 37%. Offering a quality range of 4 creams, a gel, an ointment and 2 bath additives, we now have a wider choice for your patients and more opportunities to reduce emollient spend. www.trderma.co.uk

VISIT US ON STAND J34 MARTINDALE Established over a century ago, Martindale Pharma offer a quality portfolio of products in Addiction, Ophthalmic, Critical Care, Hospital Speciality and Unlicensed Medicines. We work in genuine partnership with our customers to ensure they get the maximum benefit from our products. Come and meet the team at stand F10.

VISIT US ON STAND F10 PHARMACIST SUPPORT Celebrate 175 years of support with the profession’s independent charity. Join our team of 175 heroes and visit our inspiration gallery. It’s all happening on stand C50. Pharmacist Support provides a range of free and confidential services for pharmacists and their families, former pharmacists, trainees and MPharm students in times of need. www.pharmacistsupport.org/175-yearsof-support/

VISIT US ON STAND C50 QUEEN’S UNIVERSITY BELFAST

Save staff time and money by automating the creation of compliance aids (MDS or Blister tray) within any pharmacy environment. Our robots are working everday across the UK within Community Pharmacy, Hospital, Prison and Dispensing Doctor establishments. We help to reduce errors, speed up dispensing and free up pharmacies to focus on health promotion

WINMAN Increasingly, NHS and Independent Pharma Manufacturers are using the WinMan Advanced ERP System to manage their end-to-end production process. WinMan offers both paper based and Electronic Batch Record, delivers both efficiency and financial savings, improves quality management and ensures that production is carried in a controlled and consistent manner.

VISIT US ON STAND B1 CODE4HEALTH Code4Health is an initiative supported by NHS England to enable the best use to be made of digital tools and technology to deliver safe, high quality, efficient and compassionate care. Code4Health is launching a pharmacy community to educate, inform and create innovative digital solutions. Follow us on twitter @Code4Health

VISIT US ON STAND K37 TOTAL ASSIST Total Assist specialises in providing long and short term pharmacists, technicians and ATOs to NHS trusts and the private sector, including prisons & CCGs. Our candidates can expect consistent and rewarding locum and permanent work opportunities throughout the UK, delivered with a 24/7, personalised and knowledgeable service.

VISIT US ON STAND J60 SMARTWAY PHARMACEUTICALS Set up in 2001 Smartway Pharmaceuticals is one of the largest Pharmaceutical Wholesale Distributors in the UK. Part of the Smartway Group, the Smartway Unlicensed Medicines division is an MHRA registered approved supplier to the NHS/Private Hospitals of Unlicensed Imports, Specials, Special Obtains and our Exclusive Product Portfolio. With our robust quality framework and extensive network of global suppliers we are able to procure medicines supplying the NHS with cost effective products of the highest standards. Our strengths and fundamental belief lies in our personal service, partnership approach adding value to our customers.

VISIT US ON STAND F58 DENWARD MANUFACTURING LTD

Queen’s University Belfast has been delivering postgraduate education to pharmacists by distance learning for almost 25 years. Our new MSc Advanced Clinical Pharmacy Practice programme provides a flexible study pathway that is designed to develop the therapeutic knowledge and clinical practice skills of pharmacists to an advanced level.

For over 40 years Denward has specialised in the manufacture/provision of Medication storage solutions, essential Pharmacy/Medical Equipment and services. • Controlled Drug Cabinets Misuse of Drugs (safe custody) Regulations • Medication Cabinets/Storage Systems BS2881 and BS3621. • Auditable Electronic Locking • Drug Denaturing Kits (DenKit™) • Refrigeration • emperature Monitoring/Calibration www.denward.com

VISIT US IN THE EDUCATION HUB (H1)

VISIT US ON STAND B49

di Em sc ail ou eli Are : m nt gi e ble you .p at d Co fo el @ clo ng r a se r rs es s til lm pa ed s ia. s? c

Clinical. Production. Procurement. Optimisation. Whatever your role in pharmacy, we’ve got it covered! To support you and your education needs you can expect:  76 hours of cutting-edge content for your personal CPD programmed in conjunction with the Centre for Pharmacy Postgraduate Education (CPPE), the Royal Pharmaceutical Society (RPS) and the UK Clinical Pharmacy Association (UKCPA) amongst others.  A faculty of over 100 world-class speakers.  A new stream for 2016, the Clinical Pharmaceutics & Technical Services Theatre with content for those working in quality assurance/quality control, radio-pharmacy, aseptic services, production and manufacturing as well as procurement services and clinical trials.  Over 150 suppliers exhibiting new medicines, specialist pharmacy technology, post-graduate training, recruitment and equipment to name a few.  To celebrate the best in industry at the Clinical Pharmacy Awards and share best practice at the Poster Zone.  Hands-on training in the Simulation Zone.

BNF

 Networking with 2,300 colleagues, peers and friends in the UK’s largest industry gathering.

24/7 Lead education partner:

Leadership partner:

Accredited by:

3 easy ways to register... 1

ONLINE:

www.pharmacycongress.co.uk/newspaper

2 BY TELEPHONE: Call 0207 013 4976 or 0207 348 5256

Conference partners:

Education partners:

UK Renal Pharmacy Group

BY EMAIL: m.patel@closerstillmedia.com to see if you are eligible for a voucher code